SlideShare une entreprise Scribd logo
1  sur  160
““Never let what you cannot doNever let what you cannot do
interfere with what you can do”interfere with what you can do”
-- John WoodenJohn Wooden --
CCRN REVIEW PART 1CCRN REVIEW PART 1
Sherry L. Knowles, RN, CCRN, CRNISherry L. Knowles, RN, CCRN, CRNI

TOPICSTOPICS

Acute Coronary SyndromesAcute Coronary Syndromes

Acute Myocardial InfarctionAcute Myocardial Infarction

Heart BlocksHeart Blocks

Heart FailureHeart Failure

Cardiac AlterationsCardiac Alterations

Aortic AneurysmsAortic Aneurysms

CardiomyopathyCardiomyopathy

Shock StatesShock States

Peripheral Vascular DiseasePeripheral Vascular Disease

HemodynamicsHemodynamics

ARDSARDS

Chronic Lung DiseaseChronic Lung Disease

DrowningDrowning

PneumoniaPneumonia

PneumothoraxPneumothorax

Pulmonary EmbolismPulmonary Embolism

Respiratory FailureRespiratory Failure

Gastrointestinal AlterationsGastrointestinal Alterations

GI BleedingGI Bleeding

PancreatitisPancreatitis
CCRN REVIEW PART 1CCRN REVIEW PART 1

OBJECTIVESOBJECTIVES
1.1. Understand the different types of acute coronary syndromes.Understand the different types of acute coronary syndromes.
2.2. Identify basic coronary circulation and how it relates to different types ofIdentify basic coronary circulation and how it relates to different types of
myocardial infarctions.myocardial infarctions.
3.3. Anticipate potential complications associated with an AMI.Anticipate potential complications associated with an AMI.
4.4. Identify the standard treatment of an AMI.Identify the standard treatment of an AMI.
5.5. Distinguish between various AV blocks.Distinguish between various AV blocks.
6.6. Recognize the signs & symptoms of heart failure.Recognize the signs & symptoms of heart failure.
7.7. Identify the treatment of heart failure.Identify the treatment of heart failure.
8.8. Recognize the general definition and classifications of aortic aneurysms.Recognize the general definition and classifications of aortic aneurysms.
9.9. Understand the different types of aortic dissections.Understand the different types of aortic dissections.
10.10. Recognize the signs & symptoms of cardiomyopathy.Recognize the signs & symptoms of cardiomyopathy.
11.11. Differentiate between the different types of cardiomyopathy.Differentiate between the different types of cardiomyopathy.
12.12. Identify the treatment for the different types of cardiomyopathy.Identify the treatment for the different types of cardiomyopathy.
13.13. Understand the different stages of shock.Understand the different stages of shock.
14.14. Differentiate between different types of shock.Differentiate between different types of shock.
CCRN REVIEW PART 1CCRN REVIEW PART 1

OBJECTIVESOBJECTIVES
15.15. Distinguish between arterial and venous peripheral vascular disease.Distinguish between arterial and venous peripheral vascular disease.
16.16. Identify the various treatments for peripheral vascular disease.Identify the various treatments for peripheral vascular disease.
17.17. Define respiratory failure.Define respiratory failure.
18.18. Identify the various treatments for acute respiratory failure.Identify the various treatments for acute respiratory failure.
19.19. Recognize the signs & symptoms and causes of various respiratoryRecognize the signs & symptoms and causes of various respiratory
alterations.alterations.
20.20. Identify the standard treatment for various respiratory alterations.Identify the standard treatment for various respiratory alterations.
21.21. Identify the components of cardiac output and stroke volume.Identify the components of cardiac output and stroke volume.
22.22. Recognize the pulmonary artery catheter waveforms.Recognize the pulmonary artery catheter waveforms.
23.23. Recognize the basic treatments used for commonly seen hemodynamicRecognize the basic treatments used for commonly seen hemodynamic
profiles.profiles.
24.24. Explain the common causes of gastrointestinal bleeding.Explain the common causes of gastrointestinal bleeding.
25.25. Describe the most commonly seen treatments for GI bleeding.Describe the most commonly seen treatments for GI bleeding.
26.26. Describe the signs & symptoms of acute pancreatitis and availableDescribe the signs & symptoms of acute pancreatitis and available
treatments.treatments.
CCRN REVIEW PART 1CCRN REVIEW PART 1

Acute CoronaryAcute Coronary
SyndromesSyndromes

Acute MIAcute MI

Aortic AneurysmsAortic Aneurysms

Cardiac AlterationsCardiac Alterations
Cardiovascular ConditionsCardiovascular Conditions

CardiomyopathyCardiomyopathy

Heart BlocksHeart Blocks

Heart FailureHeart Failure

Shock StatesShock States

DEFINITIONSDEFINITIONS
– Term used to cover a group of symptomsTerm used to cover a group of symptoms
compatible with acute myocardial ischemiacompatible with acute myocardial ischemia
– Acute myocardial ischemia is insufficient bloodAcute myocardial ischemia is insufficient blood
supply to the heart muscle usually resulting fromsupply to the heart muscle usually resulting from
coronary artery diseasecoronary artery disease
Acute Coronary SyndromeAcute Coronary Syndrome

DEFINITIONDEFINITION
– Infarction occurs due to mechanical obstructionInfarction occurs due to mechanical obstruction
of a coronary artery (or branch) caused by aof a coronary artery (or branch) caused by a
thrombus, plaque rupture, coronary spasmthrombus, plaque rupture, coronary spasm
and/or dissection.and/or dissection.
– STEMI vs. NSTEMI (non-STEMI)STEMI vs. NSTEMI (non-STEMI)
Acute Myocardial InfarctionAcute Myocardial Infarction

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Complains VaryComplains Vary

May include crushing chest pain (which may or mayMay include crushing chest pain (which may or may
not radiate), back, neck, jaw, teeth and/or epigastricnot radiate), back, neck, jaw, teeth and/or epigastric
pain, SOB, nausea/vomiting and dizzinesspain, SOB, nausea/vomiting and dizziness
– ST elevations on ECGST elevations on ECG
– Elevated cardiac enzymesElevated cardiac enzymes
Acute Myocardial InfarctionAcute Myocardial Infarction

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
↑↑ PAWP,PAWP, ↓↓ CO,CO, ↑↑SVR, dysrhythmias, SSVR, dysrhythmias, S44,,
cardiac failure, cardiogenic shockcardiac failure, cardiogenic shock
– Diaphoresis, pallor, referred painsDiaphoresis, pallor, referred pains
– Diabetics and women often present abnormalDiabetics and women often present abnormal
symptomssymptoms
Acute Myocardial InfarctionAcute Myocardial Infarction
Coronary CirculationCoronary Circulation
II AVRAVR V1V1
V4V4
IIII AVL V2 V5AVL V2 V5
IIIIII AVF V3 V6AVF V3 V6
IIII
VV
12 Lead ECG12 Lead ECG

ST ELEVATIONSST ELEVATIONS
– Anterior Wall MIAnterior Wall MI
 Leads VLeads V11-V-V44

Reciprocal changes in leads II, III, and aVFReciprocal changes in leads II, III, and aVF

Area supplied by the LADArea supplied by the LAD
– Inferior Wall MIInferior Wall MI

Leads II, III and aVFLeads II, III and aVF

Reciprocal changes in leads I, and aVLReciprocal changes in leads I, and aVL

Area usually supplied by the RCAArea usually supplied by the RCA
Acute Myocardial InfarctionAcute Myocardial Infarction
 ST ELEVATIONSST ELEVATIONS
– Lateral Wall MILateral Wall MI
 I, aVL, VI, aVL, V55 and Vand V66
 Area supplied by the Circumflex arteryArea supplied by the Circumflex artery
– Posterior Wall MIPosterior Wall MI
 Reflected on the opposite wallsReflected on the opposite walls
 Opposite deflectionsOpposite deflections
Acute Myocardial InfarctionAcute Myocardial Infarction
Coronary ArteriesCoronary Arteries
Anterior Wall MIAnterior Wall MI
Inferior Wall MIInferior Wall MI
 COMPLICATIONSCOMPLICATIONS
– Dysrhythmias, heart failure, pericarditis,Dysrhythmias, heart failure, pericarditis,
ventricular aneurysms, ventricular thrombus,ventricular aneurysms, ventricular thrombus,
VSD, mitral regurgitation, papillary muscle (orVSD, mitral regurgitation, papillary muscle (or
chordae tendineae) rupture, pericardialchordae tendineae) rupture, pericardial
effusions, pericarditiseffusions, pericarditis
Acute Myocardial InfarctionAcute Myocardial Infarction

NURSING INTERVENTIONSNURSING INTERVENTIONS
– OO22
– BedrestBedrest
– Serial ECG’sSerial ECG’s
– Serial cardiac enzymesSerial cardiac enzymes
– Keep pain free (NTG. MSOKeep pain free (NTG. MSO44))
– MONAMONA (Morphine, O2, Nitroglycerin, Aspirin),(Morphine, O2, Nitroglycerin, Aspirin),
Heparin, beta-blockers, and ace inhibitors. May alsoHeparin, beta-blockers, and ace inhibitors. May also
include thrombolytics or Gp2b3a inhibitorsinclude thrombolytics or Gp2b3a inhibitors
– PCI, PTCA, IABP, CABGPCI, PTCA, IABP, CABG
Acute Myocardial InfarctionAcute Myocardial Infarction

TREATMENTTREATMENT
– Time Is Heart MuscleTime Is Heart Muscle
– Prompt ECGPrompt ECG
– Goals: Relieve pain, limit the size of theGoals: Relieve pain, limit the size of the
infarction and to prevent complicationsinfarction and to prevent complications
(primarily lethal dysrhythmias)(primarily lethal dysrhythmias)
Acute Myocardial InfarctionAcute Myocardial Infarction

TREATMENTTREATMENT
– MONAMONA (Morphine, O2, Nitroglycerin, Aspirin)(Morphine, O2, Nitroglycerin, Aspirin),,
Heparin, beta-blockers, and ace inhibitors.Heparin, beta-blockers, and ace inhibitors.
May also include thrombolytics or Gp2b3aMay also include thrombolytics or Gp2b3a
inhibitorsinhibitors
– Cardiac Catheterization (with angioplasty,Cardiac Catheterization (with angioplasty,
atherectomy and/or stent)atherectomy and/or stent)
– IABP, CABG, EducationIABP, CABG, Education
Acute Myocardial InfarctionAcute Myocardial Infarction
Balloon AngioplastyBalloon Angioplasty
Vascular Stent DeploymentVascular Stent Deployment
AtherectomyAtherectomy
 SPECIFIC TREATMENTSSPECIFIC TREATMENTS
– Inferior Wall (IWMI)Inferior Wall (IWMI)
 FluidsFluids (with RV infarct)(with RV infarct)
 InotropicsInotropics
 Afterload reducing medicationsAfterload reducing medications
– Anterior Wall (AWMI)Anterior Wall (AWMI)
 DiureticsDiuretics
 InotropicsInotropics
 Afterload reducing medicationsAfterload reducing medications
Acute Myocardial InfarctionAcute Myocardial Infarction
Aortic AneurysmsAortic Aneurysms

DEFINITIONDEFINITION
– A bulge or ballooning of the aortaA bulge or ballooning of the aorta

When the walls of the aneurysm include all threeWhen the walls of the aneurysm include all three
layers of the artery, they are called true aneurysmslayers of the artery, they are called true aneurysms

When the wall of the aneurysm include only theWhen the wall of the aneurysm include only the
outer layer, it is called a pseudo-aneurysmouter layer, it is called a pseudo-aneurysm
– May be thoracic or abdominalMay be thoracic or abdominal
Aortic AneurysmsAortic Aneurysms

CAUSESCAUSES

AtherosclerosisAtherosclerosis

Marfan syndromeMarfan syndrome

HypertensionHypertension

Crack cocaine usageCrack cocaine usage

SmokingSmoking

TraumaTrauma
Aortic Aneurysms RuptureAortic Aneurysms Rupture
 An aortic aneurysm, depending on its size, mayAn aortic aneurysm, depending on its size, may
rupture, causing life-threatening internal bleedingrupture, causing life-threatening internal bleeding
 The risk of an aneurysm rupturing increases as theThe risk of an aneurysm rupturing increases as the
aneurysm gets largeraneurysm gets larger
 The risk of rupture also depends on the location ofThe risk of rupture also depends on the location of
the aneurysmthe aneurysm
 Each year, approximately 15,000 Americans die of aEach year, approximately 15,000 Americans die of a
ruptured aortic aneurysm.ruptured aortic aneurysm.
Aortic AneurysmsAortic Aneurysms

CLASSIFICATIONSCLASSIFICATIONS
– Classified by shape, location along the aorta,Classified by shape, location along the aorta,
and how they are formedand how they are formed
– May be symmetrical in shape (fusiform) or aMay be symmetrical in shape (fusiform) or a
localized weakness of the arterial wall (saccular)localized weakness of the arterial wall (saccular)
Aortic AneurysmsAortic Aneurysms
Aortic AneurysmsAortic Aneurysms

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Often produces no symptomsOften produces no symptoms
– If an aortic aneurysm suddenly ruptures it presentsIf an aortic aneurysm suddenly ruptures it presents
with extreme abdominal or back pain, a pulsatingwith extreme abdominal or back pain, a pulsating
mass in the abdomen, and a drastic drop in bloodmass in the abdomen, and a drastic drop in blood
pressurepressure
– An increase in the size of an aneurysm means anAn increase in the size of an aneurysm means an
increased in the risk of ruptureincreased in the risk of rupture
Aortic AneurysmsAortic Aneurysms

THORACIC SIGNS & SYMPTOMSTHORACIC SIGNS & SYMPTOMS
– Back, shoulder or neck painBack, shoulder or neck pain
– Cough, due to pressure placed on the tracheaCough, due to pressure placed on the trachea
– HoarsenessHoarseness
– Strider, dyspneaStrider, dyspnea
– Difficulty swallowingDifficulty swallowing
– Swelling in the neck or armsSwelling in the neck or arms
Aortic DissectionsAortic Dissections

DEFINITIONDEFINITION
– Tearing of the inner layer of the aortic wall, whichTearing of the inner layer of the aortic wall, which
allows blood to leak into the wall itself and causesallows blood to leak into the wall itself and causes
the separation of the inner and outer layersthe separation of the inner and outer layers
– Usually associated with severe chest pain radiatingUsually associated with severe chest pain radiating
to the backto the back
Aortic DissectionsAortic Dissections
A.A. DissectionDissection
beginning in thebeginning in the
ascending aortaascending aorta
B.B. Whenever theWhenever the
ascending aortaascending aorta
is not involvedis not involved
Aortic DissectionsAortic Dissections
A.A. DissectionDissection
beginning in thebeginning in the
ascending aortaascending aorta
B.B. Whenever theWhenever the
ascending aortaascending aorta
is not involvedis not involved
Aortic DissectionsAortic Dissections
Aortic DissectionsAortic Dissections
Aortic AneurysmsAortic Aneurysms

COMPLICATIONSCOMPLICATIONS

RuptureRupture

PeripheralPeripheral embolizationembolization

InfectionInfection

SpontaneousSpontaneous occlusionocclusion of aortaof aorta
Aortic AneurysmsAortic Aneurysms

TREATMENTTREATMENT

Medical managementMedical management
– Controlled BP (within specific range)Controlled BP (within specific range)

Surgical repairSurgical repair

> 4.5 cm in Marfan patients or > 5 cm in non-> 4.5 cm in Marfan patients or > 5 cm in non-
Marfan patients will require surgicalMarfan patients will require surgical
correction or endovascular stent placementcorrection or endovascular stent placement
CardiomyopathyCardiomyopathy

DEFINITIONDEFINITION
– Diseases of the heart muscle thatDiseases of the heart muscle that
cause deterioration of the function ofcause deterioration of the function of
the myocardiumthe myocardium
CardiomyopathyCardiomyopathy

CLASSIFICATIONSCLASSIFICATIONS
– Primary / Idiopathic (intrinsicPrimary / Idiopathic (intrinsic))

Heart disease of unknown cause, although viralHeart disease of unknown cause, although viral
infection and autoimmunity are suspected causesinfection and autoimmunity are suspected causes
– Secondary (extrinsicSecondary (extrinsic))

Heart disease as a result of other systemic diseases,Heart disease as a result of other systemic diseases,
such as autoimmune diseases, CAD, valvularsuch as autoimmune diseases, CAD, valvular
disease, severe hypertension, or alcohol abusedisease, severe hypertension, or alcohol abuse
CardiomyopathyCardiomyopathy

Hypertropic CardiomyopathyHypertropic Cardiomyopathy

Restrictive CardiomyopathyRestrictive Cardiomyopathy

Dilated CardiomyopathyDilated Cardiomyopathy
Hypertropic CardiomyopathyHypertropic Cardiomyopathy

Bizarre hypertrophy of the septumBizarre hypertrophy of the septum
– Previously called IHSSPreviously called IHSS

Idiopathic Hypertropic Subaortic StenosisIdiopathic Hypertropic Subaortic Stenosis
– Known as HOCMKnown as HOCM

Hypertropic Obstructive CardiomyopathyHypertropic Obstructive Cardiomyopathy

Positive inotropic drugs ShouldPositive inotropic drugs Should NotNot Be UsedBe Used
↑↑ Contractility willContractility will ↑↑ outflow tract obstructionoutflow tract obstruction

Nitroglycerin ShouldNitroglycerin Should NotNot Be UsedBe Used
– Dilation Will Worsen The ProblemDilation Will Worsen The Problem
HarleyHarley
Hypertropic CardiomyopathyHypertropic Cardiomyopathy

TREATMENTTREATMENT
– Relax the ventriclesRelax the ventricles
 Beta BlockersBeta Blockers
 Calcium Channel BlockersCalcium Channel Blockers
– Slow the Heart RateSlow the Heart Rate
 Increase filling timeIncrease filling time
– Use Negative InotropesUse Negative Inotropes
 Optimize diastolic fillingOptimize diastolic filling
– Do Not use NTGDo Not use NTG
 Dilation will worsen the problemDilation will worsen the problem
Restrictive CardiomyopathyRestrictive Cardiomyopathy

Rigid Ventricular WallRigid Ventricular Wall
– Due to endomyocardial fibrosisDue to endomyocardial fibrosis
– Obstructs ventricular fillingObstructs ventricular filling

Least common formLeast common form
Restrictive CardiomyopathyRestrictive Cardiomyopathy

TREATMENTTREATMENT
– Positive InotropicsPositive Inotropics
– DiureticsDiuretics
– Low Sodium DietLow Sodium Diet
Dilated CardiomyopathyDilated Cardiomyopathy

Grossly dilated ventricles without hypertrophyGrossly dilated ventricles without hypertrophy
– Global left ventricular dysfunctionGlobal left ventricular dysfunction
– Leads to pooling of blood and embolic episodesLeads to pooling of blood and embolic episodes
– Leads to refractory heart failureLeads to refractory heart failure
– Leads to papillary muscle dysfunction secondary toLeads to papillary muscle dysfunction secondary to
LV dilationLV dilation
Dilated CardiomyopathyDilated Cardiomyopathy

TREATMENTTREATMENT
– Positive InotropesPositive Inotropes
– Afterload ReducersAfterload Reducers
– Anticoagulants with Atrial FibAnticoagulants with Atrial Fib
CardiomyopathiesCardiomyopathies
CardiomyopathyCardiomyopathy

GENERALIZED TREATMENTGENERALIZED TREATMENT
– Positive InotropesPositive Inotropes

Except with Hypertropic CardiomyopathyExcept with Hypertropic Cardiomyopathy
– VasodilatorsVasodilators

Except with Hypertropic CardiomyopathyExcept with Hypertropic Cardiomyopathy
– Reduce Preload & AfterloadReduce Preload & Afterload
– DiureticsDiuretics
– Beta BlockersBeta Blockers
– Calcium Channel BlockersCalcium Channel Blockers
– IABPIABP
– Vasodilators (as indicated)Vasodilators (as indicated)
– Fluid RestrictionFluid Restriction
– Daily weights, prn O2, planned activities,Daily weights, prn O2, planned activities,
education, and emotional supporteducation, and emotional support
– Consider Heart TransplantConsider Heart Transplant
BREAK!BREAK!
CCRN REVIEW PART 1CCRN REVIEW PART 1
Conduction DefectsConduction Defects

STABLE VS UNSTABLESTABLE VS UNSTABLE
– StableStable

Start with medicationsStart with medications
– UnstableUnstable

Shock (cardioversion or defibrillation)Shock (cardioversion or defibrillation)
Normal Sinus RhythmNormal Sinus Rhythm
Heart RateHeart Rate 60 - 100 bpm60 - 100 bpm
RhythmRhythm RegularRegular
P WaveP Wave Before each QRS & identicalBefore each QRS & identical
PR Interval (in seconds)PR Interval (in seconds) 0.12 to 0.200.12 to 0.20
QRS (in seconds)QRS (in seconds) < 0.12< 0.12
Atrial FibrillationAtrial Fibrillation
 AFibAFib
– Multifocal atrial impulses at rate 300-600/minMultifocal atrial impulses at rate 300-600/min
– Irregular conduction to ventriclesIrregular conduction to ventricles
Atrial FlutterAtrial Flutter
 AFLAFL
– Atrial impulses at rate of 250-350/minAtrial impulses at rate of 250-350/min
– Regularly blocked impulses at the AV nodeRegularly blocked impulses at the AV node
– Saw tooth flutter wavesSaw tooth flutter waves
Wandering Atrial PacemakerWandering Atrial Pacemaker

WAPWAP
– Multiple ectopic foci in the atriaMultiple ectopic foci in the atria
– Three or more p wave morphologiesThree or more p wave morphologies
– Rate < 100Rate < 100
Supraventricular TachycardiaSupraventricular Tachycardia

SVTSVT
– Supraventricular rhythm at rate 150-250Supraventricular rhythm at rate 150-250
– P waves cannot be positively identifiedP waves cannot be positively identified
Atrial Tach = supraventricular rhythm with p wave morphologyAtrial Tach = supraventricular rhythm with p wave morphology
that is noticeably different from the sinus p wavethat is noticeably different from the sinus p wave
Ventricular TachycardiaVentricular Tachycardia
 VTVT
– Ventricular rate of 100-250/minVentricular rate of 100-250/min
– Wide QRSWide QRS
Torsades de PointesTorsades de Pointes
 Polymorphic VTPolymorphic VT
– VT with alternating ventricular focusVT with alternating ventricular focus
– Often associated with prolonged QT Rate < 100Often associated with prolonged QT Rate < 100
Heart Blocks (AV Blocks)Heart Blocks (AV Blocks)
Sinus Rhythm with First Degree AV BlockSinus Rhythm with First Degree AV Block
Sinus Rhythm with Second Degree AV Block, Type 2Sinus Rhythm with Second Degree AV Block, Type 2
Sinus Rhythm with Second Degree AV Block, Type 1Sinus Rhythm with Second Degree AV Block, Type 1
Third Degree AV BlockThird Degree AV Block
 DEFINITIONDEFINITION
– A condition in which the heart cannot pumpA condition in which the heart cannot pump
sufficient blood to meet the metabolic needs ofsufficient blood to meet the metabolic needs of
the bodythe body
– Pulmonary (LVF) and/or systemic (RVF)Pulmonary (LVF) and/or systemic (RVF)
congestion is present.congestion is present.
Heart FailureHeart Failure

DEFINITIONDEFINITION
– Pulmonary EdemaPulmonary Edema

Fluid in the alveolus that impairs gas exchange byFluid in the alveolus that impairs gas exchange by
altering the diffusion between alveolus andaltering the diffusion between alveolus and capillarycapillary

Acute left ventricular failure causes cardiogenicAcute left ventricular failure causes cardiogenic
pulmonary edemapulmonary edema

Non-cardiogenic pulmonary edema is a synonym forNon-cardiogenic pulmonary edema is a synonym for
Adult Respiratory Distress Syndrome (ARDS)Adult Respiratory Distress Syndrome (ARDS)
Heart FailureHeart Failure

COMPENSATORY MECHANISMSCOMPENSATORY MECHANISMS
– Sympaththetic nervous system stimulationSympaththetic nervous system stimulation

TachycardiaTachycardia

Vasoconstriction and increased SVRVasoconstriction and increased SVR
– Renin-angiotensin-aldosterone systemRenin-angiotensin-aldosterone system
activation (RAAS)activation (RAAS)

Hypo perfusion to the kidneys (renin)Hypo perfusion to the kidneys (renin)

Vasoconstriction (angiotensin)Vasoconstriction (angiotensin)

Sodium and water retention (kidneys)Sodium and water retention (kidneys)

Ventricular dilationVentricular dilation
Heart FailureHeart Failure

FUNCTIONAL CLASSIFICATIONSFUNCTIONAL CLASSIFICATIONS
– Class IClass I
– Class IIClass II
– Class IIIClass III
– Class IVClass IV
Heart FailureHeart Failure
(without noticeable limitations)(without noticeable limitations)
(symptoms upon activity)(symptoms upon activity)
(severe symptoms upon activity)(severe symptoms upon activity)
(symptoms at rest)(symptoms at rest)

COMPLICATIONSCOMPLICATIONS
– HypotensionHypotension
– DysrhythmiasDysrhythmias
– Respiratory FailureRespiratory Failure
– Progressive DeteriorationProgressive Deterioration
– Acute Renal FailureAcute Renal Failure
– Fluid & Electrolyte ImbalancesFluid & Electrolyte Imbalances
Heart FailureHeart Failure

TREATMENTTREATMENT
– Improve OxygenationImprove Oxygenation
– Decrease Myocardial Oxygen DemandDecrease Myocardial Oxygen Demand
– Decrease PreloadDecrease Preload
– Decrease AfterloadDecrease Afterload
– Increase ContractilityIncrease Contractility
– Manage DysrhythmiasManage Dysrhythmias
– Educate!Educate!
Heart FailureHeart Failure
Vascular DiseaseVascular Disease
Aorto/Iliac Disease: Pre & Post PTA/StentAorto/Iliac Disease: Pre & Post PTA/Stent
Peripheral Vascular DiseasePeripheral Vascular Disease
SYMPTOMSSYMPTOMS
PAINPAIN
PAIN RELIEFPAIN RELIEF
EDEMAEDEMA
PULSESPULSES
INTEGUMENTINTEGUMENT
CHANGESCHANGES
ULCERSULCERS
SKIN TEMPERATURESKIN TEMPERATURE
SEXUAL ISSUESSEXUAL ISSUES
ARTERIALARTERIAL
Upon walkingUpon walking
On resting, standing orOn resting, standing or
dependent position of lower limbsdependent position of lower limbs
NoneNone
Decreased or absentDecreased or absent
Hair lossHair loss
Skin shinySkin shiny
Nail thickeningNail thickening
Pallor when elevatedPallor when elevated
Red when dependentRed when dependent
Ulcers located on toes, lateralUlcers located on toes, lateral
areas or site of traumaareas or site of trauma
Gangrene possibleGangrene possible
CoolCool
ImpotencyImpotency
Sexual dysfunctionSexual dysfunction
VENOUSVENOUS
While standingWhile standing
Elevation of extremitiesElevation of extremities
Present, edematousPresent, edematous
May be difficult to palpateMay be difficult to palpate
Brownish pigmentationBrownish pigmentation
May be cyanotic whenMay be cyanotic when
extremities are dependentextremities are dependent
Ulcers located on ankles,Ulcers located on ankles,
medial or pre-tibial areasmedial or pre-tibial areas
Normal or warmNormal or warm
Not presentNot present
Peripheral Vascular DiseasePeripheral Vascular Disease

TREATMENTSTREATMENTS
– MedicalMedical

Are they taking ASA, Coumadin, Ticlid, Plavix,Are they taking ASA, Coumadin, Ticlid, Plavix,
Oral Contraceptives, Hormones?Oral Contraceptives, Hormones?
– InvasiveInvasive

PTA, atherectomy, stentsPTA, atherectomy, stents
– SurgicalSurgical

GraftsGrafts
Peripheral Vascular DiseasePeripheral Vascular Disease
Bypass GraftsBypass Grafts
 DEFINITIONDEFINITION
– Inadequate perfusion to the body tissuesInadequate perfusion to the body tissues
– Low blood pressure with impaired perfusionLow blood pressure with impaired perfusion
to the end organsto the end organs
– May result in multiple organ dysfunctionMay result in multiple organ dysfunction
ShockShock

TYPES OF SHOCKTYPES OF SHOCK
– Hypovolemic ShockHypovolemic Shock
– Cardiogenic ShockCardiogenic Shock
– Distributive ShockDistributive Shock
– Obstructive ShockObstructive Shock
ShockShock
ShockShock

COMPENSATORY MECHANISMSCOMPENSATORY MECHANISMS
–TachycardiaTachycardia

Attempts to deliver more blood to the tissuesAttempts to deliver more blood to the tissues
–VasoconstrictionVasoconstriction

Attempts to maintain adequate BP in order toAttempts to maintain adequate BP in order to
adequately perfuse the body tissuesadequately perfuse the body tissues
–Increased ADH SecretionIncreased ADH Secretion

ADH makes the body hold onto water in an effort toADH makes the body hold onto water in an effort to
maintain volume and thus enough blood pressure tomaintain volume and thus enough blood pressure to
perfuse the body tissuesperfuse the body tissues
Types of ShockTypes of Shock

Hypovolemic ShockHypovolemic Shock
– Inadequate perfusion to the tissues due to insufficient intravascularInadequate perfusion to the tissues due to insufficient intravascular
volumevolume

Cardiogenic ShockCardiogenic Shock
– Inadequate perfusion to the tissues due to heart failureInadequate perfusion to the tissues due to heart failure

Distributive ShockDistributive Shock
– Inadequate perfusion to the tissues due to blood flow out of theInadequate perfusion to the tissues due to blood flow out of the
intravascular space causing insufficient intravascular volumeintravascular space causing insufficient intravascular volume
– Anaphylactic, Septic, and Spinal ShockAnaphylactic, Septic, and Spinal Shock

Obstructive ShockObstructive Shock
– Inadequate perfusion to the tissues due to obstruction of blood flowInadequate perfusion to the tissues due to obstruction of blood flow
Hypovolemic ShockHypovolemic Shock

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
Low BPLow BP TachycardiaTachycardia
Orthostatic HypotensionOrthostatic Hypotension RestlessnessRestlessness
ConfusionConfusion Agitation (or listless)Agitation (or listless)
ThirstThirst PallorPallor
Cool, Clammy SkinCool, Clammy Skin ↑↑ Resp. RateResp. Rate
↓↓ UOPUOP ↓↓ COCO
↓↓ PAWPPAWP ↓↓ CVPCVP
↑↑ SVRSVR ↑↑ Lactate LevelsLactate Levels
Hypovolemic ShockHypovolemic Shock

TREATMENTTREATMENT
–Volume (IVF, Blood)Volume (IVF, Blood)
Cardiogenic ShockCardiogenic Shock

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
Low BPLow BP RestlessnessRestlessness
Agitation (or listless)Agitation (or listless) ConfusionConfusion
TachycardiaTachycardia PallorPallor
↓↓ UOPUOP ↓↓ COCO
↑↑ PAWP (low with RVF)PAWP (low with RVF) ↑↑CVPCVP
↑↑ SVRSVR ↑↑ Lactate LevelsLactate Levels
JVDJVD Peripheral EdemaPeripheral Edema
Ventricular Gallop (S3)Ventricular Gallop (S3) DyspneaDyspnea
Pulmonary CracklesPulmonary Crackles

TREATMENTTREATMENT
BedrestBedrest O2O2
↑↑ COCO Positive InotropesPositive Inotropes
↓↓ Preload & AfterloadPreload & Afterload DiureticsDiuretics
↓↓ VasodilatorsVasodilators PositioningPositioning
↓↓ Myocardial DemandMyocardial Demand IABPIABP
Cardiogenic ShockCardiogenic Shock
Anaphylactic ShockAnaphylactic Shock

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
Low BPLow BP TachycardiaTachycardia
RestlessnessRestlessness ConfusionConfusion
Agitation (or listless)Agitation (or listless) ThirstThirst
PallorPallor Warm FeelingWarm Feeling
PruritusPruritus HivesHives
AngioedemaAngioedema BronchoconstrictionBronchoconstriction
WheezingWheezing Laryngeal EdemaLaryngeal Edema
DyspneaDyspnea Cool, Clammy SkinCool, Clammy Skin
↓↓ UOPUOP ↓↓ COCO
↓↓ PAWPPAWP ↓↓ CVPCVP
↓↓ SVRSVR ↑↑ Lactate LevelsLactate Levels

TREATMENTTREATMENT
– EpinephrineEpinephrine
– IVFIVF
– VasoconstrictorsVasoconstrictors
– Support/Maintain AirwaySupport/Maintain Airway
Anaphylactic ShockAnaphylactic Shock
Obstructive ShockObstructive Shock

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
Low BPLow BP TachycardiaTachycardia
RestlessnessRestlessness ConfusionConfusion
Agitation (or listless)Agitation (or listless) PallorPallor
Cool, Clammy SkinCool, Clammy Skin ↓↓ CO ,CO , ↓↓ UOPUOP
Symptoms related to causeSymptoms related to cause
Obstructive ShockObstructive Shock

CAUSESCAUSES
Pulmonary EmbolusPulmonary Embolus TamponadeTamponade
Tension PneumothoraxTension Pneumothorax Aortic AneurysmAortic Aneurysm

TREATMENTTREATMENT
Treat the CauseTreat the Cause

Cardiogenic Shock is the only shock withCardiogenic Shock is the only shock with  PAWPPAWP

Early (Hyperdynamic) Shock is the only shock withEarly (Hyperdynamic) Shock is the only shock with  CO andCO and 
SVRSVR

Neurogenic Shock is the only shock withNeurogenic Shock is the only shock with  BradycardiaBradycardia

Anaphylactic Shock has the definitive characteristic of wheezing dueAnaphylactic Shock has the definitive characteristic of wheezing due
to bronchospasmto bronchospasm
Parameter Hypovolemic Cardiogenic Neurogenic Anaphylactic Early Septic Late Septic
CVP/RAP      
PAWP      or Norm 
CO      
BP      
SVR      
HR     Normal 
Shock ProfilesShock Profiles
SIRS Sepsis Severe Septic MODS DeathSIRS Sepsis Severe Septic MODS Death
InfectionInfection Sepsis ShockSepsis Shock
Sepsis SyndromeSepsis Syndrome
 Sepsis
– SIRS’ response with presumed/confirmed infectionSIRS’ response with presumed/confirmed infection
 Severe Sepsis
– Sepsis associated with organ dysfunction, hypoperfusionSepsis associated with organ dysfunction, hypoperfusion
(lactic acidosis, oliguria, altered mental status etc.), or(lactic acidosis, oliguria, altered mental status etc.), or
hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)
 Septic Shock
– Sepsis with perfusion abnormalities and hypotensionSepsis with perfusion abnormalities and hypotension
despite adequate fluid resuscitationdespite adequate fluid resuscitation
Sepsis SyndromeSepsis Syndrome

EARLY STAGE (Hyperdynamic)EARLY STAGE (Hyperdynamic)
Normal BPNormal BP TachycardiaTachycardia
ConfusionConfusion Agitation (or listless)Agitation (or listless)
↑↑ Respiratory RateRespiratory Rate TemperatureTemperature
Normal ColorNormal Color Normal orNormal or ↑↑ UOPUOP
Normal PAWPNormal PAWP ↑↑ COCO ↓↓ SVRSVR

LATE STAGE (Hypodynamic)LATE STAGE (Hypodynamic)
Low BPLow BP TachycardiaTachycardia
Orthostatic HypotensionOrthostatic Hypotension RestlessnessRestlessness
ConfusionConfusion Agitation (or listless)Agitation (or listless)
ThirstThirst PallorPallor
Cool, Clammy SkinCool, Clammy Skin ↓↓ UOPUOP
↓↓ COCO ↓↓ PAWPPAWP
↓↓ CVPCVP ↑↑ SVRSVR
↑↑ Lactate LevelsLactate Levels
Septic ShockSeptic Shock
Homeostasis Gets LostHomeostasis Gets Lost
3.3. Improve PerfusionImprove Perfusion
– Prevent organ dysfunctionPrevent organ dysfunction
– Treat temp as neededTreat temp as needed
2.2. Treat The CauseTreat The Cause
– Pan culture, antibioticsPan culture, antibiotics
– Seek primary site of infectionSeek primary site of infection
– Direct therapy to primary causeDirect therapy to primary cause
1.1. Stabilize The PatientStabilize The Patient
– Fluids (lots of fluids) 150ml/hr or moreFluids (lots of fluids) 150ml/hr or more
– VasoconstrictorsVasoconstrictors
Treatment for SepsisTreatment for Sepsis
HEMODYNAMICSHEMODYNAMICS
Invasive PA CatheterInvasive PA Catheter
CONTRAINDICATIONSCONTRAINDICATIONS

Mechanical Tricuspid or Pulmonary ValveMechanical Tricuspid or Pulmonary Valve

Right Heart Mass (thrombus and/or tumor)Right Heart Mass (thrombus and/or tumor)

Tricuspid or Pulmonary Valve EndocarditisTricuspid or Pulmonary Valve Endocarditis
BasicBasic ConceptsConcepts

CO = HR X SVCO = HR X SV

BP = CO x SVRBP = CO x SVR

CO and SVR are inversely relatedCO and SVR are inversely related
CO and SVR will change before BP changesCO and SVR will change before BP changes
StrokeStroke VolumeVolume
 Components Stroke VolumeComponents Stroke Volume
– PreloadPreload:: the volume of blood in the ventriclesthe volume of blood in the ventricles
at end diastole and the stretch placed on theat end diastole and the stretch placed on the
muscle fibersmuscle fibers
– AfterloadAfterload:: the resistance the ventricles mustthe resistance the ventricles must
overcome to eject it’s volume of bloodovercome to eject it’s volume of blood
– Contractility:Contractility: the force with which the heartthe force with which the heart
muscle contracts (myocardial compliance)muscle contracts (myocardial compliance)
PAC Insertion SequencePAC Insertion Sequence
Phlebostatic AxisPhlebostatic Axis
4th ICS Mid-chest, regardless of head elevation4th ICS Mid-chest, regardless of head elevation
 RAP (CVP)RAP (CVP)
 RVPRVP
 PAPPAP
 PAWPPAWP
 SVRSVR
0-8 mmHg0-8 mmHg
15-30/0-8 mmHg15-30/0-8 mmHg
15-30/6-12 mmHg15-30/6-12 mmHg
8 - 12 mmHg8 - 12 mmHg
700-1500700-1500 dynes/sec/cmdynes/sec/cm22
Normal Hemodynamic ValuesNormal Hemodynamic Values
Normal Hemodynamic ValuesNormal Hemodynamic Values

Values normalized for body size (BSA)Values normalized for body size (BSA)
 CI:CI: 2.5 – 4.5 L/min/m2.5 – 4.5 L/min/m22
 SVRI:SVRI: 1970 – 2390 dynes/sec/cm-5/m21970 – 2390 dynes/sec/cm-5/m2
 SVI or SI:SVI or SI: 35 – 60 mL/beat/m235 – 60 mL/beat/m2
 EDVI:EDVI: 60 – 100 mL/m260 – 100 mL/m2
Mixed Venous Oxygen SaturationMixed Venous Oxygen Saturation
SvO2SvO2
 End result of O2 delivery andEnd result of O2 delivery and
consumptionconsumption
 Measured in the pulmonary arteryMeasured in the pulmonary artery
 An average estimate of venous saturation forAn average estimate of venous saturation for
the whole body.the whole body.
 Does not reflect separate tissue perfusion orDoes not reflect separate tissue perfusion or
oxygenationoxygenation
Stroke Volume Variation (SVV)Stroke Volume Variation (SVV)
 Minimally Invasive Flo TracMinimally Invasive Flo Trac
 Measured through Arterial LineMeasured through Arterial Line
 Measures preload responsivenessMeasures preload responsiveness
 SVV > 10-15 % = preload responsiveSVV > 10-15 % = preload responsive
(responsive to fluids)(responsive to fluids)
 SVV > 10-15% = pulsus paradoxusSVV > 10-15% = pulsus paradoxus
 SVV < 10–15% = not preload responsiveSVV < 10–15% = not preload responsive
Measuring PA PressuresMeasuring PA Pressures

Measure All Hemodynamic ValuesMeasure All Hemodynamic Values
at End-Expirationat End-Expiration
– ““Patient PeakPatient Peak””
– ““Vent ValleyVent Valley””
Spontaneous RespirationsSpontaneous Respirations

Measure all pressures atMeasure all pressures at end-expirationend-expiration

AtAt top curvetop curve with Spontaneous Respirationwith Spontaneous Respiration
““patient-peak”patient-peak”

Intrathoracic pressureIntrathoracic pressure decreasesdecreases duringduring
spontaneous inspirationspontaneous inspiration
– Negative deflection on waveformsNegative deflection on waveforms

Intrathoracic pressureIntrathoracic pressure increasesincreases duringduring
spontaneous expirationspontaneous expiration
– Positive deflection on waveformsPositive deflection on waveforms
Measuring PA PressuresMeasuring PA Pressures

Measure all pressures atMeasure all pressures at end-expirationend-expiration

AtAt bottom curvebottom curve with mechanical ventilatorwith mechanical ventilator
““Vent-Valley”Vent-Valley”

Intrathoracic pressureIntrathoracic pressure increasesincreases duringduring
positive pressure ventilations (inspiration)positive pressure ventilations (inspiration)
– Positive deflection on waveformsPositive deflection on waveforms

Intrathoracic pressureIntrathoracic pressure decreasesdecreases duringduring
positive pressure expirationpositive pressure expiration
– Negative deflection on waveformsNegative deflection on waveforms
Measuring PA PressuresMeasuring PA Pressures
 a-wavea-wave
– Atrial contractionAtrial contraction
– Correct location for measurement of PAWPCorrect location for measurement of PAWP
 Average the peak & trough of the a-waveAverage the peak & trough of the a-wave
– Begins near the end of QRS or at the QTBegins near the end of QRS or at the QT
segmentsegment
 Delayed ECG correlation from CVP sinceDelayed ECG correlation from CVP since
PA catheter is further away from left atriumPA catheter is further away from left atrium
PAWP WaveformPAWP Waveform

c-wavec-wave
– Rarely presentRarely present
– Represents mitral valve closureRepresents mitral valve closure

v-wavev-wave
– Represents left atrial fillingRepresents left atrial filling
– Begins at about the end of the T waveBegins at about the end of the T wave
PAWP WaveformPAWP Waveform
PAWP WaveformPAWP Waveform
BREAK!BREAK!
CCRN REVIEW PART 1CCRN REVIEW PART 1

ARDSARDS

DrowningDrowning

PneumothoraxPneumothorax

RespiratoryRespiratory
FailureFailure
Respiratory AlterationsRespiratory Alterations

ChronicChronic LungLung
DiseaseDisease

PneumoniaPneumonia

PulmonaryPulmonary
EmbolismEmbolism
ARDSARDS

DEFINITIONSDEFINITIONS
– Severe respiratory failure associated with pulmonarySevere respiratory failure associated with pulmonary
infiltrates (similar to infant hyaline membrane disease)infiltrates (similar to infant hyaline membrane disease)
– Pulmonary edema in the absence of fluid overload orPulmonary edema in the absence of fluid overload or
depressed LV function (Non-cardiogenic pulmonary edema)depressed LV function (Non-cardiogenic pulmonary edema)
– Originates from a number of insults involving damage to theOriginates from a number of insults involving damage to the
alveolar-capillary membranealveolar-capillary membrane
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
ARDSARDS

PATHOPHYSIOLOGYPATHOPHYSIOLOGY
– Inflammatory mediators are released causing extensiveInflammatory mediators are released causing extensive
structural damagestructural damage
– Increased permeability of pulmonary microvasculatureIncreased permeability of pulmonary microvasculature
causes leakage of proteinaceous fluid across the alveolar–causes leakage of proteinaceous fluid across the alveolar–
capillary membranecapillary membrane
– Also causes damage to the surfactant-producing type II cellsAlso causes damage to the surfactant-producing type II cells
ARDSARDS

CXR CHARACTERISTICSCXR CHARACTERISTICS
– Normal size heartNormal size heart
– No pleural effusionNo pleural effusion
– Ground GlassGround Glass appearanceappearance
– Often normal early in the disease but may rapidlyOften normal early in the disease but may rapidly
progress to complete whiteoutprogress to complete whiteout
ARDSARDS
ARDSARDS

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Symptoms develop 24 to 48 hours of injurySymptoms develop 24 to 48 hours of injury

Sudden progressive disorderSudden progressive disorder

Pulmonary edemaPulmonary edema

Severe dyspneaSevere dyspnea

HypoxemiaHypoxemia REFRACTORYREFRACTORY to O2to O2

Decreased lung complianceDecreased lung compliance

Diffuse pulmonary infiltratesDiffuse pulmonary infiltrates
– Symptoms may be minimal compared to CXRSymptoms may be minimal compared to CXR
– Rales may be heardRales may be heard
ARDSARDS
Common RiskCommon Risk
FactorsFactors
Other Risk FactorsOther Risk Factors
SepsisSepsis
MassiveMassive
TraumaTrauma
ShockShock
MultipleMultiple
TransfusionsTransfusions
PneumoniaPneumonia
AspirationAspiration
InfectionInfection
Smoke inhalationSmoke inhalation
Inhaled toxinsInhaled toxins
BurnsBurns
Near DrowningNear Drowning
DKADKA
PregnancyPregnancy
EclampsiaEclampsia
Amniotic Fluid EmbolusAmniotic Fluid Embolus
DrugsDrugs
Acute PancreatitisAcute Pancreatitis
DICDIC
Head InjuryHead Injury
↑ ICPICP
Fat EmboliFat Emboli
Blood ProductsBlood Products
Heart/Lung BypassHeart/Lung Bypass
Tumor LysisTumor Lysis
Pulmonary ContusionPulmonary Contusion
NarcoticsNarcotics

RISK FACTORSRISK FACTORS
ARDSARDS

TREATMENTTREATMENT
– Respiratory SupportRespiratory Support
– PEEP, CPAPPEEP, CPAP
Chronic Lung DiseaseChronic Lung Disease

COPDCOPD
– Presents with hyper-inflated lung fieldsPresents with hyper-inflated lung fields

Due to chronic air trappingDue to chronic air trapping

May be barrel chestedMay be barrel chested
– May lead to cor pulmonaleMay lead to cor pulmonale (right-sided heart failure)(right-sided heart failure)

Due to chronic high pulmonary pressuresDue to chronic high pulmonary pressures
– Often hypercarbic (high pCO2)Often hypercarbic (high pCO2)

Often dependent upon hypoxic driveOften dependent upon hypoxic drive
Chronic Lung DiseaseChronic Lung Disease

COPD TREATMENTCOPD TREATMENT
– Avoid overuse of oxygenAvoid overuse of oxygen (except in emergencies)(except in emergencies)
– BronchodilatorsBronchodilators
– SteroidsSteroids
– HydrationHydration
– EducationEducation

Pursed Lip BreathingPursed Lip Breathing

Leaning UprightLeaning Upright
Near DrowningNear Drowning

Salt WaterSalt Water
– Causes body fluids to shift into lungsCauses body fluids to shift into lungs

Osmosis: From low to high concentrationOsmosis: From low to high concentration

Results in hemoconcentration & hypovolemiaResults in hemoconcentration & hypovolemia
– Results in acute pulmonary edemaResults in acute pulmonary edema

Fresh WaterFresh Water
– Fluids shift into body tissuesFluids shift into body tissues

Results in hemodilution & hypervolemiaResults in hemodilution & hypervolemia

Can result in gross edemaCan result in gross edema
– Damaged alveoli fill with proteinaceous fluidDamaged alveoli fill with proteinaceous fluid

May lead to pulmonary edemaMay lead to pulmonary edema
PneumoniaPneumonia

Lung infection (bacterial, viral, or fungal)Lung infection (bacterial, viral, or fungal)
– Most commonly caused by SMost commonly caused by Streptococcustreptococcus
pneumoniaepneumoniae

Symptoms include fever, pleuretic chestSymptoms include fever, pleuretic chest
pain, productive cough, and tachypneapain, productive cough, and tachypnea
– Often presents bronchial breath sounds over theOften presents bronchial breath sounds over the
lung arealung area

Treatment involves giving the right antibioticTreatment involves giving the right antibiotic
PneumothoraxPneumothorax

DEFINITIONSDEFINITIONS
– Simple pneumothoraxSimple pneumothorax

Results from buildup of air or pressure in the pleural spaceResults from buildup of air or pressure in the pleural space
– Spontaneous pneumothoraxSpontaneous pneumothorax

May be due to blebs that ruptureMay be due to blebs that rupture

The 2 key risk factors are increased chest length andThe 2 key risk factors are increased chest length and
cigarette smokingcigarette smoking
– Tension pneumothoraxTension pneumothorax

Involves a buildup of air in the pleural space due toInvolves a buildup of air in the pleural space due to
one-way movement of airone-way movement of air

Progressively worsensProgressively worsens

Requires immediate interventionRequires immediate intervention
PneumothoraxPneumothorax
Tension PneumothoraxTension Pneumothorax
PneumothoraxPneumothorax

CAUSESCAUSES
– BarotraumaBarotrauma
– InjuryInjury
– BlebsBlebs
PneumothoraxPneumothorax

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Standard PneumothoraxStandard Pneumothorax

Sharp "pleuritic" chest pain, worse on breathingSharp "pleuritic" chest pain, worse on breathing

Sudden shortness of breathSudden shortness of breath

Dry, hacking cough (may occur due to irritationDry, hacking cough (may occur due to irritation
of the diaphragm)of the diaphragm)

May cause mediastinal shiftMay cause mediastinal shift
– Tension pneumothoraxTension pneumothorax

Signs of standard pneumothorax with signs ofSigns of standard pneumothorax with signs of
cardiovascular collapsecardiovascular collapse

Immediately life threateningImmediately life threatening

May cause mediastinal shiftMay cause mediastinal shift
PneumothoraxPneumothorax

TREATMENTTREATMENT

Spontaneous pneumothoraxSpontaneous pneumothorax
– Depends on symptoms & size of pneumothoraxDepends on symptoms & size of pneumothorax
– Provide respiratory supportProvide respiratory support
– May need chest tube or needle decompressionMay need chest tube or needle decompression

Some resolve without interventionSome resolve without intervention

Tension pneumothoraxTension pneumothorax
– RequiresRequires immediateimmediate interventionintervention
– May cause cardiovascular collapseMay cause cardiovascular collapse
– May need chest tube or needle decompressionMay need chest tube or needle decompression

22ndnd
intercostal spaceintercostal space

TREATMENTTREATMENT
– PleurodesisPleurodesis
PneumothoraxPneumothorax

Chemical or surgical adhesion of the lungChemical or surgical adhesion of the lung
to the chest wallto the chest wall

Used for multiple collapsed lungs orUsed for multiple collapsed lungs or
persistent collapsepersistent collapse
Flail ChestFlail Chest
 DefinitionDefinition
 Signs & SymptomsSigns & Symptoms
Pulmonary EmbolismPulmonary Embolism
– Arterial embolus that obstructs blood flow to the lungArterial embolus that obstructs blood flow to the lung
– Symptoms include sudden dyspnea, cough, chestSymptoms include sudden dyspnea, cough, chest
pain, hemoptysis and sinus tachycardiapain, hemoptysis and sinus tachycardia
– Blood gas shows low pO2 & low pCO2Blood gas shows low pO2 & low pCO2
– May present positive Homan’s SignMay present positive Homan’s Sign
– May present loud S2May present loud S2

Diagnostic TestsDiagnostic Tests
– CXRCXR
– VQ ScanVQ Scan
– Spiral CTSpiral CT
– Pulmonary arteriogram/angiogramPulmonary arteriogram/angiogram
– Venous ultrasound of the lower extremitiesVenous ultrasound of the lower extremities
– ABG with low pO2 & low pCO2ABG with low pO2 & low pCO2
– D-DimerD-Dimer
Pulmonary EmbolismPulmonary Embolism

TreatmentTreatment
– Requires immediate interventionRequires immediate intervention
– Provide respiratory supportProvide respiratory support
– Treat pain & comfortTreat pain & comfort
– Usually includes intravenous heparinUsually includes intravenous heparin

Heparin reduces risk of secondaryHeparin reduces risk of secondary
thrombus formation while clot is reabsorbedthrombus formation while clot is reabsorbed
– May require embolectomyMay require embolectomy
– May require thrombolysisMay require thrombolysis
– May need umbrella filterMay need umbrella filter
– May need long term anticoagulantsMay need long term anticoagulants
Pulmonary EmbolismPulmonary Embolism
Respiratory FailureRespiratory Failure

DEFINITIONSDEFINITIONS
– Failure to maintain adequate gas exchangeFailure to maintain adequate gas exchange
– Inadequate blood oxygenation or CO2 removalInadequate blood oxygenation or CO2 removal
– PaO2 < 50 mmHg and/or PaCO2 > 50 mmHgPaO2 < 50 mmHg and/or PaCO2 > 50 mmHg
and/or pH < 7.35and/or pH < 7.35 on Room Airon Room Air
Respiratory FailureRespiratory Failure
TYPE ITYPE I HypoxemiaHypoxemia withoutwithout hypercapniahypercapnia
TYPE IITYPE II HypoxemiaHypoxemia withwith hypercapniahypercapnia
Respiratory FailureRespiratory Failure

CAUSESCAUSES
– V/Q MismatchingV/Q Mismatching
– Intrapulmonary ShuntingIntrapulmonary Shunting
– Alveolar HypoventilationAlveolar Hypoventilation
Respiratory FailureRespiratory Failure

V/Q MISMATCHINGV/Q MISMATCHING
– COPDCOPD
– Interstitial Lung DiseaseInterstitial Lung Disease
– Pulmonary EmbolismPulmonary Embolism
Respiratory FailureRespiratory Failure

PULMONARY SHUNTINGPULMONARY SHUNTING
– AV fistulas/malformationsAV fistulas/malformations
– Alveolar collapse (atelectasis)Alveolar collapse (atelectasis)
– Alveolar consolidation (pneumonia)Alveolar consolidation (pneumonia)
– Excessive mucus accumulationExcessive mucus accumulation
Respiratory FailureRespiratory Failure

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Restlessness / AgitationRestlessness / Agitation
– Confusion /Confusion / ↓↓ LOCLOC
– Tachycardia / DysrhythmiasTachycardia / Dysrhythmias
– Tachypnea / DyspneaTachypnea / Dyspnea
– Cool, clammy, pale skinCool, clammy, pale skin
Respiratory FailureRespiratory Failure

ARTERIAL BLOOD GASESARTERIAL BLOOD GASES
– pH 7.30 / pO2 45 / pCO2 80pH 7.30 / pO2 45 / pCO2 80
– pH 7.30 / pO2 55 / pCO2 65pH 7.30 / pO2 55 / pCO2 65
– pH 7.32 / pO2 50 / pCO2 50pH 7.32 / pO2 50 / pCO2 50
– pH 7.55 / pO2 65 / pCO2 22pH 7.55 / pO2 65 / pCO2 22
Respiratory FailureRespiratory Failure

TREATMENTTREATMENT
– Ensure Adequate VentilationEnsure Adequate Ventilation
↑↑ FiO2FiO2

Ineffective with shuntingIneffective with shunting

Prolonged O2 > 40% causes O2 toxicityProlonged O2 > 40% causes O2 toxicity

Must use caution with CO2 retainersMust use caution with CO2 retainers
– Chronic hypercapnia causes CO2 retainersChronic hypercapnia causes CO2 retainers
to use hypoxic driveto use hypoxic drive
– Too much O2 can depress respirationsToo much O2 can depress respirations
BREAK!BREAK!
CCRN REVIEW PART 1CCRN REVIEW PART 1

GI BleedGI Bleed

PancreatitisPancreatitis
Gastrointestinal AlterationsGastrointestinal Alterations

CAUSESCAUSES
– UGI BleedingUGI Bleeding

Includes the esophagus, stomach, duodenumIncludes the esophagus, stomach, duodenum
– Peptic Ulcer Disease (PUD), or Esophageal VaricesPeptic Ulcer Disease (PUD), or Esophageal Varices
– ASA, NSAID’s, Anticoagulants, AlcoholASA, NSAID’s, Anticoagulants, Alcohol
– H. PyloriH. Pylori
– LGI BleedingLGI Bleeding

Includes the jejunum, ileum, colon, rectumIncludes the jejunum, ileum, colon, rectum
– Colorectal cancer, Polyps, Hemorrhoids, IBDColorectal cancer, Polyps, Hemorrhoids, IBD
Gastrointestinal BleedingGastrointestinal Bleeding
Gastrointestinal BleedingGastrointestinal Bleeding
Gastrointestinal BleedingGastrointestinal Bleeding

HematemesisHematemesis – vomiting of blood (or coffee ground– vomiting of blood (or coffee ground
material) (indicates bleeding above the duodenum )material) (indicates bleeding above the duodenum )

MelenaMelena – passage of black tarry stools > 50ml (indicates– passage of black tarry stools > 50ml (indicates
degradation of blood in the bowel)degradation of blood in the bowel)

HematocheziaHematochezia – passage of red blood (rectal bleeding)– passage of red blood (rectal bleeding)

Occult BleedingOccult Bleeding – bleeding that is not apparent to the– bleeding that is not apparent to the
patient and results from small amounts of bloodpatient and results from small amounts of blood

Obscure BleedingObscure Bleeding – occult or obvious but source not– occult or obvious but source not
identifiedidentified
Gastrointestinal BleedingGastrointestinal Bleeding

HematemesisHematemesis –– always UGI sourcealways UGI source

MelanaMelana –– indicates blood has been in GI tractindicates blood has been in GI tract
for extended periodsfor extended periods
– Mostly UGIMostly UGI
– Small bowelSmall bowel
– Rt colon (if bleeding relatively slow)Rt colon (if bleeding relatively slow)

HematocheziaHematochezia
– Mostly colonMostly colon
– Massive UGI bleeding (not enough time for degradation)Massive UGI bleeding (not enough time for degradation)

TREATMENTTREATMENT
– Find the underlying causeFind the underlying cause
– Fluid volume replacementFluid volume replacement
– Endoscopy or colonoscopyEndoscopy or colonoscopy
– Medical and /or surgical therapyMedical and /or surgical therapy

SomatostatinSomatostatin

IV or intra-arterial vasopressinIV or intra-arterial vasopressin

SclerotherpaySclerotherpay

Angiography with embolizationAngiography with embolization

ElectrocoagulationElectrocoagulation

Band ligationBand ligation

Balloon tamponade (Sengstaken-Blackmore tube)Balloon tamponade (Sengstaken-Blackmore tube)
Gastrointestinal BleedingGastrointestinal Bleeding
The PancreasThe Pancreas

The Pancreas secretes digestive enzymes,The Pancreas secretes digestive enzymes,
bicarbonate, water, and some electrolytes intobicarbonate, water, and some electrolytes into
the duodenum via the pancreatic ductthe duodenum via the pancreatic duct
– Lipase, Amylase, TrypsinLipase, Amylase, Trypsin

The Pancreas also producesThe Pancreas also produces
and secretes insulinand secretes insulin
PancreatitisPancreatitis

DEFINITIONDEFINITION
– An autodigestive process resultingAn autodigestive process resulting
from premature activation offrom premature activation of
pancreatic enzymespancreatic enzymes
PancreatitisPancreatitis

PATHOSHYSIOLOGYPATHOSHYSIOLOGY
• Inactive pancreatic enzymes are activated outsideInactive pancreatic enzymes are activated outside
of the duodenumof the duodenum
• The swelling pancreas causes fluids to shift intoThe swelling pancreas causes fluids to shift into
the retro peritoneum and bowelthe retro peritoneum and bowel
• Fluid shifts can cause severe hypovolemia andFluid shifts can cause severe hypovolemia and
hypotensionhypotension
• Inflammation cause commotion around pancreasInflammation cause commotion around pancreas
PancreatitisPancreatitis

MANY CAUSESMANY CAUSES
– AlcoholismAlcoholism
– Biliary DiseaseBiliary Disease
– GallstonesGallstones
– InfectionsInfections
– HyperparathyroidismHyperparathyroidism
– HypertriglyceridemiaHypertriglyceridemia
– HypercalcemiaHypercalcemia
– Peptic Ulcer DiseasePeptic Ulcer Disease
– Cystic FibrosisCystic Fibrosis
– Vascular DiseaseVascular Disease
– Multiple DrugsMultiple Drugs
– Much Much MoreMuch Much More
PancreatitisPancreatitis

SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Abdominal PainAbdominal Pain
– Nausea & VomitingNausea & Vomiting
– Abdominal DistentionAbdominal Distention
– JaundiceJaundice
– MalnutritionMalnutrition
– HematemesisHematemesis
– Grey Turner’s SignGrey Turner’s Sign
– Cullen’s SignCullen’s Sign
– Elevated Amylase,Elevated Amylase,
Lipase, LDH, AST, WBC’sLipase, LDH, AST, WBC’s
BUN, and GlucoseBUN, and Glucose
PancreatitisPancreatitis

COMPLICATIONSCOMPLICATIONS
– HypocalcemiaHypocalcemia
– HypotensionHypotension
– Acute Tubular NecrosisAcute Tubular Necrosis
– DICDIC
– Obstructive JaundiceObstructive Jaundice
– Erosive GastritisErosive Gastritis
– Paralytic IleusParalytic Ileus
– Pseudocyst or AbscessPseudocyst or Abscess
– Bowel InfarctionBowel Infarction
– Internal BleedingInternal Bleeding
– Fat NecrosisFat Necrosis
– Pleural Effusion (left)Pleural Effusion (left)
– Pulmonary InfiltratesPulmonary Infiltrates
– HypoxemiaHypoxemia
– AtelectasisAtelectasis
– ARDSARDS
– Pericardial EffusionPericardial Effusion
– Mediastinal AbscessMediastinal Abscess
– HyperglycemiaHyperglycemia
– HypertriglyceridemiaHypertriglyceridemia
– EncephalopathyEncephalopathy
PancreatitisPancreatitis

TREATMENTTREATMENT
– StabilizationStabilization

Correct Fluid AndCorrect Fluid And
Electrolyte StatusElectrolyte Status
– Respiratory SupportRespiratory Support
– Control PainControl Pain

DemerolDemerol
– NG TubeNG Tube

NPONPO
– TPNTPN

Restricted DietRestricted Diet
– Monitor For ComplicationsMonitor For Complications
– Monitor Blood SugarMonitor Blood Sugar
– Drug TherapiesDrug Therapies

Somatostatin,Somatostatin,
AnticholinergicsAnticholinergics
– Watch For Signs OfWatch For Signs Of
InfectionInfection
– PrayPray
PancreatitisPancreatitis

FULMINATING PANCREATITISFULMINATING PANCREATITIS
• Overwhelming formOverwhelming form
• Necrotizing formNecrotizing form
• Extreme symptomsExtreme symptoms
• Seen with ESRF patientsSeen with ESRF patients
• May lead to ARDS & DICMay lead to ARDS & DIC
PancreatitisPancreatitis

FULMINATING PANCREATITISFULMINATING PANCREATITIS
• Signs & SymptomsSigns & Symptoms

Tachycardia & low BP (may be the only sign)Tachycardia & low BP (may be the only sign)

Pulmonary & cerebral insufficiencyPulmonary & cerebral insufficiency

Acute diabetic ketosis or oliguriaAcute diabetic ketosis or oliguria

Hemorrhagic pancreatitis may appearHemorrhagic pancreatitis may appear
THE ENDTHE END
PART 1PART 1
CCRN REVIEWCCRN REVIEW
THANK YOUTHANK YOU
CCRN REVIEW PART 1CCRN REVIEW PART 1
ReferencesReferences
 American Heart Association. (2005). Guidelines 2005 for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care. Available at:
www.americanheart.org.
 Bridges EJ.(2006) Pulmonary artery pressure monitoring: when, how, and what
else to use. AACN Adv Crit Care. 2006;17(3):286–303.
 Chulay, M., Burns S. M. (2006). AACN Essentials of Critical Care Nursing.
McGraw-Hill Companies, Inc., Chapter 23.
 Finkelmeier, B., Marolda, D. (2004) Aortic Dissection, Journal of Cardiovascular
Nursing: 15(4):15–24.
 Hughes E. (2004). Understanding the care of patients with acute pancreatitis.
Nurs Standard: (18) pgs 45-54.
 Sole, M. L., Klein, D. G. & Moseley, M. (2008). Introduction to Critical Care
Nursing. 5th ed. Philadelphia, Pa: Saunders.
 Thelan, L. A., Urden, L. D., Lough, M. E. (2006). Critical care: Diagnosis and
Treatment for repair of abdominal aortic aneurysm. St. Louis, Mo.:
Mosby/Elsevier. pg 145-188.
References ContinuedReferences Continued
 Urden, L., Lough, M. E. & Stacy, K. L. (2009). Thelan's Critical Care Nursing:
Diagnosis and Management (6th ed). St. Louis, Mo.: Mosby/Elsevier.
 Woods, S., Sivarajan Froelicher, E. S., & Motzer, S. U. (2004). Cardiac Nursing.
5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins.
 Wynne J, Braunwald E. (2004). The Cardiomyopathies in Braunwald's Heart
Disease: A Textbook of Cardiovascular Medicine (7th Edition). Philadelphia:
W.B. Saunders, vol. 2, pps. 1659–1696, 1751–1803.
 Zimmerman & Sole. (2001). Critical Care Nursing (3rd Edition). WB Saunders.,
pgs. 41-80, 176-180, 242-266.
 Anderson, L. (July 2001). Abdominal Aortic Aneurysm, Journal of
Cardiovascular Nursing:15(4):1–14, July 2001.
 Irwin, R. S.; Rippe, J. M. (January 2003). Intensive Care Medicine. Lippincott
Williams & Wilkins, Philadelphia: pgs. 35-548.
 Wung, S., Aouizerat, B. E. (Nov/Dec 2004). Aortic Aneurysms. Journal of
Cardiovascular Nursing. Lippincott Williams & Wilkins, Inc.:19(6):409-416, 34(2).

Contenu connexe

Tendances

CONTRAST ECHOCARDIOGRAPHY
CONTRAST ECHOCARDIOGRAPHYCONTRAST ECHOCARDIOGRAPHY
CONTRAST ECHOCARDIOGRAPHYsoumenprasad
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardiaPraveen Nagula
 
Cardiac anatomy and physiology
Cardiac anatomy and physiologyCardiac anatomy and physiology
Cardiac anatomy and physiologyJose Escanuela
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditisWaqas Khalid
 
Recurrent ventricular arrhythmia after cardiac surgery
Recurrent ventricular arrhythmia after cardiac surgeryRecurrent ventricular arrhythmia after cardiac surgery
Recurrent ventricular arrhythmia after cardiac surgerysalah_atta
 
stable coronary artery disease
stable coronary artery diseasestable coronary artery disease
stable coronary artery diseasemagdy elmasry
 
HCM – Presentation, Hemodynamics and Intervention
HCM – Presentation, Hemodynamics and InterventionHCM – Presentation, Hemodynamics and Intervention
HCM – Presentation, Hemodynamics and InterventionAnkur Gupta
 
Basic haemodynamic assessment with echo (iHeartScan)
Basic haemodynamic assessment with echo (iHeartScan)Basic haemodynamic assessment with echo (iHeartScan)
Basic haemodynamic assessment with echo (iHeartScan)SCGH ED CME
 
Basic Rhythm Strip Review
Basic Rhythm Strip ReviewBasic Rhythm Strip Review
Basic Rhythm Strip ReviewSherry Knowles
 
Valvular Heart Disease
Valvular Heart DiseaseValvular Heart Disease
Valvular Heart DiseaseEneutron
 
Hemodynamic assessment in cardiology
Hemodynamic assessment in cardiologyHemodynamic assessment in cardiology
Hemodynamic assessment in cardiologySujit Sahu
 
Infective endocarditis Echocardiography
Infective endocarditis EchocardiographyInfective endocarditis Echocardiography
Infective endocarditis EchocardiographySruthi Meenaxshi
 
Trials on oral anti platelet agents
Trials on oral anti platelet agentsTrials on oral anti platelet agents
Trials on oral anti platelet agentsVijay Yadav
 

Tendances (20)

CONTRAST ECHOCARDIOGRAPHY
CONTRAST ECHOCARDIOGRAPHYCONTRAST ECHOCARDIOGRAPHY
CONTRAST ECHOCARDIOGRAPHY
 
Echo class 2_05262015
Echo class 2_05262015Echo class 2_05262015
Echo class 2_05262015
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Cardiac anatomy and physiology
Cardiac anatomy and physiologyCardiac anatomy and physiology
Cardiac anatomy and physiology
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditis
 
Recurrent ventricular arrhythmia after cardiac surgery
Recurrent ventricular arrhythmia after cardiac surgeryRecurrent ventricular arrhythmia after cardiac surgery
Recurrent ventricular arrhythmia after cardiac surgery
 
stable coronary artery disease
stable coronary artery diseasestable coronary artery disease
stable coronary artery disease
 
HCM – Presentation, Hemodynamics and Intervention
HCM – Presentation, Hemodynamics and InterventionHCM – Presentation, Hemodynamics and Intervention
HCM – Presentation, Hemodynamics and Intervention
 
Pacemaker basics
Pacemaker basicsPacemaker basics
Pacemaker basics
 
Basic haemodynamic assessment with echo (iHeartScan)
Basic haemodynamic assessment with echo (iHeartScan)Basic haemodynamic assessment with echo (iHeartScan)
Basic haemodynamic assessment with echo (iHeartScan)
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
 
Basic Rhythm Strip Review
Basic Rhythm Strip ReviewBasic Rhythm Strip Review
Basic Rhythm Strip Review
 
Valvular Heart Disease
Valvular Heart DiseaseValvular Heart Disease
Valvular Heart Disease
 
Hemodynamic assessment in cardiology
Hemodynamic assessment in cardiologyHemodynamic assessment in cardiology
Hemodynamic assessment in cardiology
 
Aortic Regurgitation - Rivin
Aortic Regurgitation - RivinAortic Regurgitation - Rivin
Aortic Regurgitation - Rivin
 
Infective endocarditis Echocardiography
Infective endocarditis EchocardiographyInfective endocarditis Echocardiography
Infective endocarditis Echocardiography
 
Cardiac tamponade
Cardiac tamponadeCardiac tamponade
Cardiac tamponade
 
Valvular heart disease for post graduates
Valvular heart disease for post graduates Valvular heart disease for post graduates
Valvular heart disease for post graduates
 
Trials on oral anti platelet agents
Trials on oral anti platelet agentsTrials on oral anti platelet agents
Trials on oral anti platelet agents
 

En vedette

CCRN Review Part 2 (of 2)
CCRN Review Part 2 (of 2)CCRN Review Part 2 (of 2)
CCRN Review Part 2 (of 2)Sherry Knowles
 
CCRN Review Part 1 (of 2)
CCRN Review Part 1 (of 2)CCRN Review Part 1 (of 2)
CCRN Review Part 1 (of 2)Sherry Knowles
 
PCCN Review Part 2 (of 2)
PCCN Review Part 2 (of 2)PCCN Review Part 2 (of 2)
PCCN Review Part 2 (of 2)Sherry Knowles
 
Digestive System Disorder
Digestive System DisorderDigestive System Disorder
Digestive System DisorderSivanna Health
 
Common Critical Conditions
Common Critical ConditionsCommon Critical Conditions
Common Critical ConditionsSherry Knowles
 
Brain Aneurysms & AV Malformations
Brain Aneurysms & AV MalformationsBrain Aneurysms & AV Malformations
Brain Aneurysms & AV MalformationsSherry Knowles
 
Electrolyte Disturbances
Electrolyte DisturbancesElectrolyte Disturbances
Electrolyte DisturbancesSherry Knowles
 
A D V A N C E D P A C I N G
A D V A N C E D  P A C I N GA D V A N C E D  P A C I N G
A D V A N C E D P A C I N GSherry Knowles
 
Gastrointestinal disease
Gastrointestinal diseaseGastrointestinal disease
Gastrointestinal diseaseIAU Dent
 
Cardiovascular Drugs
Cardiovascular DrugsCardiovascular Drugs
Cardiovascular DrugsJess Little
 
Gastrointestinal Disorders
Gastrointestinal DisordersGastrointestinal Disorders
Gastrointestinal DisordersSherry Knowles
 

En vedette (20)

CCRN Review Part 2 (of 2)
CCRN Review Part 2 (of 2)CCRN Review Part 2 (of 2)
CCRN Review Part 2 (of 2)
 
CCRN Review part 2
CCRN Review part 2CCRN Review part 2
CCRN Review part 2
 
Pccn Review Part 2
Pccn Review Part 2Pccn Review Part 2
Pccn Review Part 2
 
Hemodynamics
HemodynamicsHemodynamics
Hemodynamics
 
CCRN Review Part 1 (of 2)
CCRN Review Part 1 (of 2)CCRN Review Part 1 (of 2)
CCRN Review Part 1 (of 2)
 
Hemodynamics
HemodynamicsHemodynamics
Hemodynamics
 
PCCN Review Part 2 (of 2)
PCCN Review Part 2 (of 2)PCCN Review Part 2 (of 2)
PCCN Review Part 2 (of 2)
 
C X R Interpretation
C X R  InterpretationC X R  Interpretation
C X R Interpretation
 
Access 4 U
Access 4 UAccess 4 U
Access 4 U
 
Digestive System Disorder
Digestive System DisorderDigestive System Disorder
Digestive System Disorder
 
Common Critical Conditions
Common Critical ConditionsCommon Critical Conditions
Common Critical Conditions
 
Arterial Blood Gases
Arterial Blood GasesArterial Blood Gases
Arterial Blood Gases
 
Brain Aneurysms & AV Malformations
Brain Aneurysms & AV MalformationsBrain Aneurysms & AV Malformations
Brain Aneurysms & AV Malformations
 
Electrolyte Disturbances
Electrolyte DisturbancesElectrolyte Disturbances
Electrolyte Disturbances
 
A D V A N C E D P A C I N G
A D V A N C E D  P A C I N GA D V A N C E D  P A C I N G
A D V A N C E D P A C I N G
 
Gastrointestinal disease
Gastrointestinal diseaseGastrointestinal disease
Gastrointestinal disease
 
Arterial Blood Gases
Arterial Blood GasesArterial Blood Gases
Arterial Blood Gases
 
Cardiovascular Drugs
Cardiovascular DrugsCardiovascular Drugs
Cardiovascular Drugs
 
Drug Classifications
Drug ClassificationsDrug Classifications
Drug Classifications
 
Gastrointestinal Disorders
Gastrointestinal DisordersGastrointestinal Disorders
Gastrointestinal Disorders
 

Similaire à CCRN Review part 1

3.Ischemic heart disease( coronary artery disease)
3.Ischemic heart disease( coronary artery disease)3.Ischemic heart disease( coronary artery disease)
3.Ischemic heart disease( coronary artery disease)PNK SINGH
 
Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Dr Khalid Hasan Khan
 
Venticular conduction disorders by dr vinay verma
Venticular conduction disorders  by dr vinay vermaVenticular conduction disorders  by dr vinay verma
Venticular conduction disorders by dr vinay vermaDr Harikrishna Harindran
 
Ischaemic Heart Disease
Ischaemic Heart Disease Ischaemic Heart Disease
Ischaemic Heart Disease Evith Pereira
 
Rhythms of the Heart
Rhythms of the HeartRhythms of the Heart
Rhythms of the HeartEneutron
 
Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)Malleswara rao Dangeti
 
Inferior myocardial infarction
Inferior myocardial infarction Inferior myocardial infarction
Inferior myocardial infarction Praveen Nagula
 
Vascular stressors
Vascular stressorsVascular stressors
Vascular stressorsEneutron
 
Non invasive diagnosis of hf
Non invasive diagnosis of hfNon invasive diagnosis of hf
Non invasive diagnosis of hfRehab Al Ashry
 
2.5. Regurgitant Murmurs.pptx
2.5. Regurgitant Murmurs.pptx2.5. Regurgitant Murmurs.pptx
2.5. Regurgitant Murmurs.pptxAmareDejene
 
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02Afroza Prioty
 
2 cardiac emergencies
2 cardiac emergencies2 cardiac emergencies
2 cardiac emergenciesachsan raider
 
History of arrhythmias
History of arrhythmiasHistory of arrhythmias
History of arrhythmiasasadsoomro1960
 
2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...
2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...
2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...Centro Diagnostico Nardi
 

Similaire à CCRN Review part 1 (20)

Pccn Review Part 1
Pccn Review Part 1Pccn Review Part 1
Pccn Review Part 1
 
3.Ischemic heart disease( coronary artery disease)
3.Ischemic heart disease( coronary artery disease)3.Ischemic heart disease( coronary artery disease)
3.Ischemic heart disease( coronary artery disease)
 
Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8
 
Venticular conduction disorders by dr vinay verma
Venticular conduction disorders  by dr vinay vermaVenticular conduction disorders  by dr vinay verma
Venticular conduction disorders by dr vinay verma
 
Cvs examination
Cvs examination Cvs examination
Cvs examination
 
Ischaemic Heart Disease
Ischaemic Heart Disease Ischaemic Heart Disease
Ischaemic Heart Disease
 
Rhythms of the Heart
Rhythms of the HeartRhythms of the Heart
Rhythms of the Heart
 
Pericardial disease
Pericardial diseasePericardial disease
Pericardial disease
 
Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)
 
Inferior myocardial infarction
Inferior myocardial infarction Inferior myocardial infarction
Inferior myocardial infarction
 
Vascular stressors
Vascular stressorsVascular stressors
Vascular stressors
 
Non invasive diagnosis of hf
Non invasive diagnosis of hfNon invasive diagnosis of hf
Non invasive diagnosis of hf
 
2.5. Regurgitant Murmurs.pptx
2.5. Regurgitant Murmurs.pptx2.5. Regurgitant Murmurs.pptx
2.5. Regurgitant Murmurs.pptx
 
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
 
Cardiac tamponade Toufiqur Rahman
Cardiac tamponade Toufiqur RahmanCardiac tamponade Toufiqur Rahman
Cardiac tamponade Toufiqur Rahman
 
2 cardiac emergencies
2 cardiac emergencies2 cardiac emergencies
2 cardiac emergencies
 
Cvs ihd-csbrp
Cvs ihd-csbrpCvs ihd-csbrp
Cvs ihd-csbrp
 
Pericardial Disease
Pericardial DiseasePericardial Disease
Pericardial Disease
 
History of arrhythmias
History of arrhythmiasHistory of arrhythmias
History of arrhythmias
 
2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...
2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...
2008 napoli, congresso italo americano di cardiochirurgia, i dispositivi di c...
 

Plus de Sherry Knowles

Plus de Sherry Knowles (13)

CCRN Prep 2019 Pulmonary
CCRN Prep 2019 PulmonaryCCRN Prep 2019 Pulmonary
CCRN Prep 2019 Pulmonary
 
Rhythm Strip Review
Rhythm Strip ReviewRhythm Strip Review
Rhythm Strip Review
 
Levels Of Nursing Practice
Levels Of Nursing PracticeLevels Of Nursing Practice
Levels Of Nursing Practice
 
Heart Sounds And Murmurs
Heart Sounds And MurmursHeart Sounds And Murmurs
Heart Sounds And Murmurs
 
Drug Classifications
Drug ClassificationsDrug Classifications
Drug Classifications
 
Blood Products
Blood ProductsBlood Products
Blood Products
 
Advanced Hemodynamics
Advanced HemodynamicsAdvanced Hemodynamics
Advanced Hemodynamics
 
Blood Products
Blood ProductsBlood Products
Blood Products
 
Calculations
CalculationsCalculations
Calculations
 
Critical Medications
Critical MedicationsCritical Medications
Critical Medications
 
Common Endocrine Disorders
Common Endocrine DisordersCommon Endocrine Disorders
Common Endocrine Disorders
 
Sepsis
SepsisSepsis
Sepsis
 
Time Management
Time ManagementTime Management
Time Management
 

Dernier

JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...anjaliyadav012327
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...Pooja Nehwal
 

Dernier (20)

JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
 

CCRN Review part 1

  • 1. ““Never let what you cannot doNever let what you cannot do interfere with what you can do”interfere with what you can do” -- John WoodenJohn Wooden -- CCRN REVIEW PART 1CCRN REVIEW PART 1 Sherry L. Knowles, RN, CCRN, CRNISherry L. Knowles, RN, CCRN, CRNI
  • 2.  TOPICSTOPICS  Acute Coronary SyndromesAcute Coronary Syndromes  Acute Myocardial InfarctionAcute Myocardial Infarction  Heart BlocksHeart Blocks  Heart FailureHeart Failure  Cardiac AlterationsCardiac Alterations  Aortic AneurysmsAortic Aneurysms  CardiomyopathyCardiomyopathy  Shock StatesShock States  Peripheral Vascular DiseasePeripheral Vascular Disease  HemodynamicsHemodynamics  ARDSARDS  Chronic Lung DiseaseChronic Lung Disease  DrowningDrowning  PneumoniaPneumonia  PneumothoraxPneumothorax  Pulmonary EmbolismPulmonary Embolism  Respiratory FailureRespiratory Failure  Gastrointestinal AlterationsGastrointestinal Alterations  GI BleedingGI Bleeding  PancreatitisPancreatitis CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 3.  OBJECTIVESOBJECTIVES 1.1. Understand the different types of acute coronary syndromes.Understand the different types of acute coronary syndromes. 2.2. Identify basic coronary circulation and how it relates to different types ofIdentify basic coronary circulation and how it relates to different types of myocardial infarctions.myocardial infarctions. 3.3. Anticipate potential complications associated with an AMI.Anticipate potential complications associated with an AMI. 4.4. Identify the standard treatment of an AMI.Identify the standard treatment of an AMI. 5.5. Distinguish between various AV blocks.Distinguish between various AV blocks. 6.6. Recognize the signs & symptoms of heart failure.Recognize the signs & symptoms of heart failure. 7.7. Identify the treatment of heart failure.Identify the treatment of heart failure. 8.8. Recognize the general definition and classifications of aortic aneurysms.Recognize the general definition and classifications of aortic aneurysms. 9.9. Understand the different types of aortic dissections.Understand the different types of aortic dissections. 10.10. Recognize the signs & symptoms of cardiomyopathy.Recognize the signs & symptoms of cardiomyopathy. 11.11. Differentiate between the different types of cardiomyopathy.Differentiate between the different types of cardiomyopathy. 12.12. Identify the treatment for the different types of cardiomyopathy.Identify the treatment for the different types of cardiomyopathy. 13.13. Understand the different stages of shock.Understand the different stages of shock. 14.14. Differentiate between different types of shock.Differentiate between different types of shock. CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 4.  OBJECTIVESOBJECTIVES 15.15. Distinguish between arterial and venous peripheral vascular disease.Distinguish between arterial and venous peripheral vascular disease. 16.16. Identify the various treatments for peripheral vascular disease.Identify the various treatments for peripheral vascular disease. 17.17. Define respiratory failure.Define respiratory failure. 18.18. Identify the various treatments for acute respiratory failure.Identify the various treatments for acute respiratory failure. 19.19. Recognize the signs & symptoms and causes of various respiratoryRecognize the signs & symptoms and causes of various respiratory alterations.alterations. 20.20. Identify the standard treatment for various respiratory alterations.Identify the standard treatment for various respiratory alterations. 21.21. Identify the components of cardiac output and stroke volume.Identify the components of cardiac output and stroke volume. 22.22. Recognize the pulmonary artery catheter waveforms.Recognize the pulmonary artery catheter waveforms. 23.23. Recognize the basic treatments used for commonly seen hemodynamicRecognize the basic treatments used for commonly seen hemodynamic profiles.profiles. 24.24. Explain the common causes of gastrointestinal bleeding.Explain the common causes of gastrointestinal bleeding. 25.25. Describe the most commonly seen treatments for GI bleeding.Describe the most commonly seen treatments for GI bleeding. 26.26. Describe the signs & symptoms of acute pancreatitis and availableDescribe the signs & symptoms of acute pancreatitis and available treatments.treatments. CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 5.  Acute CoronaryAcute Coronary SyndromesSyndromes  Acute MIAcute MI  Aortic AneurysmsAortic Aneurysms  Cardiac AlterationsCardiac Alterations Cardiovascular ConditionsCardiovascular Conditions  CardiomyopathyCardiomyopathy  Heart BlocksHeart Blocks  Heart FailureHeart Failure  Shock StatesShock States
  • 6.  DEFINITIONSDEFINITIONS – Term used to cover a group of symptomsTerm used to cover a group of symptoms compatible with acute myocardial ischemiacompatible with acute myocardial ischemia – Acute myocardial ischemia is insufficient bloodAcute myocardial ischemia is insufficient blood supply to the heart muscle usually resulting fromsupply to the heart muscle usually resulting from coronary artery diseasecoronary artery disease Acute Coronary SyndromeAcute Coronary Syndrome
  • 7.  DEFINITIONDEFINITION – Infarction occurs due to mechanical obstructionInfarction occurs due to mechanical obstruction of a coronary artery (or branch) caused by aof a coronary artery (or branch) caused by a thrombus, plaque rupture, coronary spasmthrombus, plaque rupture, coronary spasm and/or dissection.and/or dissection. – STEMI vs. NSTEMI (non-STEMI)STEMI vs. NSTEMI (non-STEMI) Acute Myocardial InfarctionAcute Myocardial Infarction
  • 8.  SIGNS & SYMPTOMSSIGNS & SYMPTOMS – Complains VaryComplains Vary  May include crushing chest pain (which may or mayMay include crushing chest pain (which may or may not radiate), back, neck, jaw, teeth and/or epigastricnot radiate), back, neck, jaw, teeth and/or epigastric pain, SOB, nausea/vomiting and dizzinesspain, SOB, nausea/vomiting and dizziness – ST elevations on ECGST elevations on ECG – Elevated cardiac enzymesElevated cardiac enzymes Acute Myocardial InfarctionAcute Myocardial Infarction
  • 9.  SIGNS & SYMPTOMSSIGNS & SYMPTOMS ↑↑ PAWP,PAWP, ↓↓ CO,CO, ↑↑SVR, dysrhythmias, SSVR, dysrhythmias, S44,, cardiac failure, cardiogenic shockcardiac failure, cardiogenic shock – Diaphoresis, pallor, referred painsDiaphoresis, pallor, referred pains – Diabetics and women often present abnormalDiabetics and women often present abnormal symptomssymptoms Acute Myocardial InfarctionAcute Myocardial Infarction
  • 11. II AVRAVR V1V1 V4V4 IIII AVL V2 V5AVL V2 V5 IIIIII AVF V3 V6AVF V3 V6 IIII VV 12 Lead ECG12 Lead ECG
  • 12.  ST ELEVATIONSST ELEVATIONS – Anterior Wall MIAnterior Wall MI  Leads VLeads V11-V-V44  Reciprocal changes in leads II, III, and aVFReciprocal changes in leads II, III, and aVF  Area supplied by the LADArea supplied by the LAD – Inferior Wall MIInferior Wall MI  Leads II, III and aVFLeads II, III and aVF  Reciprocal changes in leads I, and aVLReciprocal changes in leads I, and aVL  Area usually supplied by the RCAArea usually supplied by the RCA Acute Myocardial InfarctionAcute Myocardial Infarction
  • 13.  ST ELEVATIONSST ELEVATIONS – Lateral Wall MILateral Wall MI  I, aVL, VI, aVL, V55 and Vand V66  Area supplied by the Circumflex arteryArea supplied by the Circumflex artery – Posterior Wall MIPosterior Wall MI  Reflected on the opposite wallsReflected on the opposite walls  Opposite deflectionsOpposite deflections Acute Myocardial InfarctionAcute Myocardial Infarction
  • 17.  COMPLICATIONSCOMPLICATIONS – Dysrhythmias, heart failure, pericarditis,Dysrhythmias, heart failure, pericarditis, ventricular aneurysms, ventricular thrombus,ventricular aneurysms, ventricular thrombus, VSD, mitral regurgitation, papillary muscle (orVSD, mitral regurgitation, papillary muscle (or chordae tendineae) rupture, pericardialchordae tendineae) rupture, pericardial effusions, pericarditiseffusions, pericarditis Acute Myocardial InfarctionAcute Myocardial Infarction
  • 18.  NURSING INTERVENTIONSNURSING INTERVENTIONS – OO22 – BedrestBedrest – Serial ECG’sSerial ECG’s – Serial cardiac enzymesSerial cardiac enzymes – Keep pain free (NTG. MSOKeep pain free (NTG. MSO44)) – MONAMONA (Morphine, O2, Nitroglycerin, Aspirin),(Morphine, O2, Nitroglycerin, Aspirin), Heparin, beta-blockers, and ace inhibitors. May alsoHeparin, beta-blockers, and ace inhibitors. May also include thrombolytics or Gp2b3a inhibitorsinclude thrombolytics or Gp2b3a inhibitors – PCI, PTCA, IABP, CABGPCI, PTCA, IABP, CABG Acute Myocardial InfarctionAcute Myocardial Infarction
  • 19.  TREATMENTTREATMENT – Time Is Heart MuscleTime Is Heart Muscle – Prompt ECGPrompt ECG – Goals: Relieve pain, limit the size of theGoals: Relieve pain, limit the size of the infarction and to prevent complicationsinfarction and to prevent complications (primarily lethal dysrhythmias)(primarily lethal dysrhythmias) Acute Myocardial InfarctionAcute Myocardial Infarction
  • 20.  TREATMENTTREATMENT – MONAMONA (Morphine, O2, Nitroglycerin, Aspirin)(Morphine, O2, Nitroglycerin, Aspirin),, Heparin, beta-blockers, and ace inhibitors.Heparin, beta-blockers, and ace inhibitors. May also include thrombolytics or Gp2b3aMay also include thrombolytics or Gp2b3a inhibitorsinhibitors – Cardiac Catheterization (with angioplasty,Cardiac Catheterization (with angioplasty, atherectomy and/or stent)atherectomy and/or stent) – IABP, CABG, EducationIABP, CABG, Education Acute Myocardial InfarctionAcute Myocardial Infarction
  • 24.  SPECIFIC TREATMENTSSPECIFIC TREATMENTS – Inferior Wall (IWMI)Inferior Wall (IWMI)  FluidsFluids (with RV infarct)(with RV infarct)  InotropicsInotropics  Afterload reducing medicationsAfterload reducing medications – Anterior Wall (AWMI)Anterior Wall (AWMI)  DiureticsDiuretics  InotropicsInotropics  Afterload reducing medicationsAfterload reducing medications Acute Myocardial InfarctionAcute Myocardial Infarction
  • 25. Aortic AneurysmsAortic Aneurysms  DEFINITIONDEFINITION – A bulge or ballooning of the aortaA bulge or ballooning of the aorta  When the walls of the aneurysm include all threeWhen the walls of the aneurysm include all three layers of the artery, they are called true aneurysmslayers of the artery, they are called true aneurysms  When the wall of the aneurysm include only theWhen the wall of the aneurysm include only the outer layer, it is called a pseudo-aneurysmouter layer, it is called a pseudo-aneurysm – May be thoracic or abdominalMay be thoracic or abdominal
  • 26. Aortic AneurysmsAortic Aneurysms  CAUSESCAUSES  AtherosclerosisAtherosclerosis  Marfan syndromeMarfan syndrome  HypertensionHypertension  Crack cocaine usageCrack cocaine usage  SmokingSmoking  TraumaTrauma
  • 27. Aortic Aneurysms RuptureAortic Aneurysms Rupture  An aortic aneurysm, depending on its size, mayAn aortic aneurysm, depending on its size, may rupture, causing life-threatening internal bleedingrupture, causing life-threatening internal bleeding  The risk of an aneurysm rupturing increases as theThe risk of an aneurysm rupturing increases as the aneurysm gets largeraneurysm gets larger  The risk of rupture also depends on the location ofThe risk of rupture also depends on the location of the aneurysmthe aneurysm  Each year, approximately 15,000 Americans die of aEach year, approximately 15,000 Americans die of a ruptured aortic aneurysm.ruptured aortic aneurysm.
  • 28. Aortic AneurysmsAortic Aneurysms  CLASSIFICATIONSCLASSIFICATIONS – Classified by shape, location along the aorta,Classified by shape, location along the aorta, and how they are formedand how they are formed – May be symmetrical in shape (fusiform) or aMay be symmetrical in shape (fusiform) or a localized weakness of the arterial wall (saccular)localized weakness of the arterial wall (saccular)
  • 30. Aortic AneurysmsAortic Aneurysms  SIGNS & SYMPTOMSSIGNS & SYMPTOMS – Often produces no symptomsOften produces no symptoms – If an aortic aneurysm suddenly ruptures it presentsIf an aortic aneurysm suddenly ruptures it presents with extreme abdominal or back pain, a pulsatingwith extreme abdominal or back pain, a pulsating mass in the abdomen, and a drastic drop in bloodmass in the abdomen, and a drastic drop in blood pressurepressure – An increase in the size of an aneurysm means anAn increase in the size of an aneurysm means an increased in the risk of ruptureincreased in the risk of rupture
  • 31. Aortic AneurysmsAortic Aneurysms  THORACIC SIGNS & SYMPTOMSTHORACIC SIGNS & SYMPTOMS – Back, shoulder or neck painBack, shoulder or neck pain – Cough, due to pressure placed on the tracheaCough, due to pressure placed on the trachea – HoarsenessHoarseness – Strider, dyspneaStrider, dyspnea – Difficulty swallowingDifficulty swallowing – Swelling in the neck or armsSwelling in the neck or arms
  • 32. Aortic DissectionsAortic Dissections  DEFINITIONDEFINITION – Tearing of the inner layer of the aortic wall, whichTearing of the inner layer of the aortic wall, which allows blood to leak into the wall itself and causesallows blood to leak into the wall itself and causes the separation of the inner and outer layersthe separation of the inner and outer layers – Usually associated with severe chest pain radiatingUsually associated with severe chest pain radiating to the backto the back
  • 33. Aortic DissectionsAortic Dissections A.A. DissectionDissection beginning in thebeginning in the ascending aortaascending aorta B.B. Whenever theWhenever the ascending aortaascending aorta is not involvedis not involved
  • 34. Aortic DissectionsAortic Dissections A.A. DissectionDissection beginning in thebeginning in the ascending aortaascending aorta B.B. Whenever theWhenever the ascending aortaascending aorta is not involvedis not involved
  • 37. Aortic AneurysmsAortic Aneurysms  COMPLICATIONSCOMPLICATIONS  RuptureRupture  PeripheralPeripheral embolizationembolization  InfectionInfection  SpontaneousSpontaneous occlusionocclusion of aortaof aorta
  • 38. Aortic AneurysmsAortic Aneurysms  TREATMENTTREATMENT  Medical managementMedical management – Controlled BP (within specific range)Controlled BP (within specific range)  Surgical repairSurgical repair  > 4.5 cm in Marfan patients or > 5 cm in non-> 4.5 cm in Marfan patients or > 5 cm in non- Marfan patients will require surgicalMarfan patients will require surgical correction or endovascular stent placementcorrection or endovascular stent placement
  • 39. CardiomyopathyCardiomyopathy  DEFINITIONDEFINITION – Diseases of the heart muscle thatDiseases of the heart muscle that cause deterioration of the function ofcause deterioration of the function of the myocardiumthe myocardium
  • 40. CardiomyopathyCardiomyopathy  CLASSIFICATIONSCLASSIFICATIONS – Primary / Idiopathic (intrinsicPrimary / Idiopathic (intrinsic))  Heart disease of unknown cause, although viralHeart disease of unknown cause, although viral infection and autoimmunity are suspected causesinfection and autoimmunity are suspected causes – Secondary (extrinsicSecondary (extrinsic))  Heart disease as a result of other systemic diseases,Heart disease as a result of other systemic diseases, such as autoimmune diseases, CAD, valvularsuch as autoimmune diseases, CAD, valvular disease, severe hypertension, or alcohol abusedisease, severe hypertension, or alcohol abuse
  • 41. CardiomyopathyCardiomyopathy  Hypertropic CardiomyopathyHypertropic Cardiomyopathy  Restrictive CardiomyopathyRestrictive Cardiomyopathy  Dilated CardiomyopathyDilated Cardiomyopathy
  • 42. Hypertropic CardiomyopathyHypertropic Cardiomyopathy  Bizarre hypertrophy of the septumBizarre hypertrophy of the septum – Previously called IHSSPreviously called IHSS  Idiopathic Hypertropic Subaortic StenosisIdiopathic Hypertropic Subaortic Stenosis – Known as HOCMKnown as HOCM  Hypertropic Obstructive CardiomyopathyHypertropic Obstructive Cardiomyopathy  Positive inotropic drugs ShouldPositive inotropic drugs Should NotNot Be UsedBe Used ↑↑ Contractility willContractility will ↑↑ outflow tract obstructionoutflow tract obstruction  Nitroglycerin ShouldNitroglycerin Should NotNot Be UsedBe Used – Dilation Will Worsen The ProblemDilation Will Worsen The Problem
  • 44. Hypertropic CardiomyopathyHypertropic Cardiomyopathy  TREATMENTTREATMENT – Relax the ventriclesRelax the ventricles  Beta BlockersBeta Blockers  Calcium Channel BlockersCalcium Channel Blockers – Slow the Heart RateSlow the Heart Rate  Increase filling timeIncrease filling time – Use Negative InotropesUse Negative Inotropes  Optimize diastolic fillingOptimize diastolic filling – Do Not use NTGDo Not use NTG  Dilation will worsen the problemDilation will worsen the problem
  • 45. Restrictive CardiomyopathyRestrictive Cardiomyopathy  Rigid Ventricular WallRigid Ventricular Wall – Due to endomyocardial fibrosisDue to endomyocardial fibrosis – Obstructs ventricular fillingObstructs ventricular filling  Least common formLeast common form
  • 46. Restrictive CardiomyopathyRestrictive Cardiomyopathy  TREATMENTTREATMENT – Positive InotropicsPositive Inotropics – DiureticsDiuretics – Low Sodium DietLow Sodium Diet
  • 47. Dilated CardiomyopathyDilated Cardiomyopathy  Grossly dilated ventricles without hypertrophyGrossly dilated ventricles without hypertrophy – Global left ventricular dysfunctionGlobal left ventricular dysfunction – Leads to pooling of blood and embolic episodesLeads to pooling of blood and embolic episodes – Leads to refractory heart failureLeads to refractory heart failure – Leads to papillary muscle dysfunction secondary toLeads to papillary muscle dysfunction secondary to LV dilationLV dilation
  • 48. Dilated CardiomyopathyDilated Cardiomyopathy  TREATMENTTREATMENT – Positive InotropesPositive Inotropes – Afterload ReducersAfterload Reducers – Anticoagulants with Atrial FibAnticoagulants with Atrial Fib
  • 50. CardiomyopathyCardiomyopathy  GENERALIZED TREATMENTGENERALIZED TREATMENT – Positive InotropesPositive Inotropes  Except with Hypertropic CardiomyopathyExcept with Hypertropic Cardiomyopathy – VasodilatorsVasodilators  Except with Hypertropic CardiomyopathyExcept with Hypertropic Cardiomyopathy – Reduce Preload & AfterloadReduce Preload & Afterload – DiureticsDiuretics – Beta BlockersBeta Blockers – Calcium Channel BlockersCalcium Channel Blockers – IABPIABP – Vasodilators (as indicated)Vasodilators (as indicated) – Fluid RestrictionFluid Restriction – Daily weights, prn O2, planned activities,Daily weights, prn O2, planned activities, education, and emotional supporteducation, and emotional support – Consider Heart TransplantConsider Heart Transplant
  • 51. BREAK!BREAK! CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 52. Conduction DefectsConduction Defects  STABLE VS UNSTABLESTABLE VS UNSTABLE – StableStable  Start with medicationsStart with medications – UnstableUnstable  Shock (cardioversion or defibrillation)Shock (cardioversion or defibrillation)
  • 53. Normal Sinus RhythmNormal Sinus Rhythm Heart RateHeart Rate 60 - 100 bpm60 - 100 bpm RhythmRhythm RegularRegular P WaveP Wave Before each QRS & identicalBefore each QRS & identical PR Interval (in seconds)PR Interval (in seconds) 0.12 to 0.200.12 to 0.20 QRS (in seconds)QRS (in seconds) < 0.12< 0.12
  • 54. Atrial FibrillationAtrial Fibrillation  AFibAFib – Multifocal atrial impulses at rate 300-600/minMultifocal atrial impulses at rate 300-600/min – Irregular conduction to ventriclesIrregular conduction to ventricles
  • 55. Atrial FlutterAtrial Flutter  AFLAFL – Atrial impulses at rate of 250-350/minAtrial impulses at rate of 250-350/min – Regularly blocked impulses at the AV nodeRegularly blocked impulses at the AV node – Saw tooth flutter wavesSaw tooth flutter waves
  • 56. Wandering Atrial PacemakerWandering Atrial Pacemaker  WAPWAP – Multiple ectopic foci in the atriaMultiple ectopic foci in the atria – Three or more p wave morphologiesThree or more p wave morphologies – Rate < 100Rate < 100
  • 57. Supraventricular TachycardiaSupraventricular Tachycardia  SVTSVT – Supraventricular rhythm at rate 150-250Supraventricular rhythm at rate 150-250 – P waves cannot be positively identifiedP waves cannot be positively identified Atrial Tach = supraventricular rhythm with p wave morphologyAtrial Tach = supraventricular rhythm with p wave morphology that is noticeably different from the sinus p wavethat is noticeably different from the sinus p wave
  • 58. Ventricular TachycardiaVentricular Tachycardia  VTVT – Ventricular rate of 100-250/minVentricular rate of 100-250/min – Wide QRSWide QRS
  • 59. Torsades de PointesTorsades de Pointes  Polymorphic VTPolymorphic VT – VT with alternating ventricular focusVT with alternating ventricular focus – Often associated with prolonged QT Rate < 100Often associated with prolonged QT Rate < 100
  • 60. Heart Blocks (AV Blocks)Heart Blocks (AV Blocks) Sinus Rhythm with First Degree AV BlockSinus Rhythm with First Degree AV Block Sinus Rhythm with Second Degree AV Block, Type 2Sinus Rhythm with Second Degree AV Block, Type 2 Sinus Rhythm with Second Degree AV Block, Type 1Sinus Rhythm with Second Degree AV Block, Type 1 Third Degree AV BlockThird Degree AV Block
  • 61.  DEFINITIONDEFINITION – A condition in which the heart cannot pumpA condition in which the heart cannot pump sufficient blood to meet the metabolic needs ofsufficient blood to meet the metabolic needs of the bodythe body – Pulmonary (LVF) and/or systemic (RVF)Pulmonary (LVF) and/or systemic (RVF) congestion is present.congestion is present. Heart FailureHeart Failure
  • 62.  DEFINITIONDEFINITION – Pulmonary EdemaPulmonary Edema  Fluid in the alveolus that impairs gas exchange byFluid in the alveolus that impairs gas exchange by altering the diffusion between alveolus andaltering the diffusion between alveolus and capillarycapillary  Acute left ventricular failure causes cardiogenicAcute left ventricular failure causes cardiogenic pulmonary edemapulmonary edema  Non-cardiogenic pulmonary edema is a synonym forNon-cardiogenic pulmonary edema is a synonym for Adult Respiratory Distress Syndrome (ARDS)Adult Respiratory Distress Syndrome (ARDS) Heart FailureHeart Failure
  • 63.  COMPENSATORY MECHANISMSCOMPENSATORY MECHANISMS – Sympaththetic nervous system stimulationSympaththetic nervous system stimulation  TachycardiaTachycardia  Vasoconstriction and increased SVRVasoconstriction and increased SVR – Renin-angiotensin-aldosterone systemRenin-angiotensin-aldosterone system activation (RAAS)activation (RAAS)  Hypo perfusion to the kidneys (renin)Hypo perfusion to the kidneys (renin)  Vasoconstriction (angiotensin)Vasoconstriction (angiotensin)  Sodium and water retention (kidneys)Sodium and water retention (kidneys)  Ventricular dilationVentricular dilation Heart FailureHeart Failure
  • 64.  FUNCTIONAL CLASSIFICATIONSFUNCTIONAL CLASSIFICATIONS – Class IClass I – Class IIClass II – Class IIIClass III – Class IVClass IV Heart FailureHeart Failure (without noticeable limitations)(without noticeable limitations) (symptoms upon activity)(symptoms upon activity) (severe symptoms upon activity)(severe symptoms upon activity) (symptoms at rest)(symptoms at rest)
  • 65.  COMPLICATIONSCOMPLICATIONS – HypotensionHypotension – DysrhythmiasDysrhythmias – Respiratory FailureRespiratory Failure – Progressive DeteriorationProgressive Deterioration – Acute Renal FailureAcute Renal Failure – Fluid & Electrolyte ImbalancesFluid & Electrolyte Imbalances Heart FailureHeart Failure
  • 66.  TREATMENTTREATMENT – Improve OxygenationImprove Oxygenation – Decrease Myocardial Oxygen DemandDecrease Myocardial Oxygen Demand – Decrease PreloadDecrease Preload – Decrease AfterloadDecrease Afterload – Increase ContractilityIncrease Contractility – Manage DysrhythmiasManage Dysrhythmias – Educate!Educate! Heart FailureHeart Failure
  • 67. Vascular DiseaseVascular Disease Aorto/Iliac Disease: Pre & Post PTA/StentAorto/Iliac Disease: Pre & Post PTA/Stent
  • 68. Peripheral Vascular DiseasePeripheral Vascular Disease SYMPTOMSSYMPTOMS PAINPAIN PAIN RELIEFPAIN RELIEF EDEMAEDEMA PULSESPULSES INTEGUMENTINTEGUMENT CHANGESCHANGES ULCERSULCERS SKIN TEMPERATURESKIN TEMPERATURE SEXUAL ISSUESSEXUAL ISSUES ARTERIALARTERIAL Upon walkingUpon walking On resting, standing orOn resting, standing or dependent position of lower limbsdependent position of lower limbs NoneNone Decreased or absentDecreased or absent Hair lossHair loss Skin shinySkin shiny Nail thickeningNail thickening Pallor when elevatedPallor when elevated Red when dependentRed when dependent Ulcers located on toes, lateralUlcers located on toes, lateral areas or site of traumaareas or site of trauma Gangrene possibleGangrene possible CoolCool ImpotencyImpotency Sexual dysfunctionSexual dysfunction VENOUSVENOUS While standingWhile standing Elevation of extremitiesElevation of extremities Present, edematousPresent, edematous May be difficult to palpateMay be difficult to palpate Brownish pigmentationBrownish pigmentation May be cyanotic whenMay be cyanotic when extremities are dependentextremities are dependent Ulcers located on ankles,Ulcers located on ankles, medial or pre-tibial areasmedial or pre-tibial areas Normal or warmNormal or warm Not presentNot present
  • 69. Peripheral Vascular DiseasePeripheral Vascular Disease  TREATMENTSTREATMENTS – MedicalMedical  Are they taking ASA, Coumadin, Ticlid, Plavix,Are they taking ASA, Coumadin, Ticlid, Plavix, Oral Contraceptives, Hormones?Oral Contraceptives, Hormones? – InvasiveInvasive  PTA, atherectomy, stentsPTA, atherectomy, stents – SurgicalSurgical  GraftsGrafts
  • 70. Peripheral Vascular DiseasePeripheral Vascular Disease Bypass GraftsBypass Grafts
  • 71.  DEFINITIONDEFINITION – Inadequate perfusion to the body tissuesInadequate perfusion to the body tissues – Low blood pressure with impaired perfusionLow blood pressure with impaired perfusion to the end organsto the end organs – May result in multiple organ dysfunctionMay result in multiple organ dysfunction ShockShock
  • 72.  TYPES OF SHOCKTYPES OF SHOCK – Hypovolemic ShockHypovolemic Shock – Cardiogenic ShockCardiogenic Shock – Distributive ShockDistributive Shock – Obstructive ShockObstructive Shock ShockShock
  • 73. ShockShock  COMPENSATORY MECHANISMSCOMPENSATORY MECHANISMS –TachycardiaTachycardia  Attempts to deliver more blood to the tissuesAttempts to deliver more blood to the tissues –VasoconstrictionVasoconstriction  Attempts to maintain adequate BP in order toAttempts to maintain adequate BP in order to adequately perfuse the body tissuesadequately perfuse the body tissues –Increased ADH SecretionIncreased ADH Secretion  ADH makes the body hold onto water in an effort toADH makes the body hold onto water in an effort to maintain volume and thus enough blood pressure tomaintain volume and thus enough blood pressure to perfuse the body tissuesperfuse the body tissues
  • 74. Types of ShockTypes of Shock  Hypovolemic ShockHypovolemic Shock – Inadequate perfusion to the tissues due to insufficient intravascularInadequate perfusion to the tissues due to insufficient intravascular volumevolume  Cardiogenic ShockCardiogenic Shock – Inadequate perfusion to the tissues due to heart failureInadequate perfusion to the tissues due to heart failure  Distributive ShockDistributive Shock – Inadequate perfusion to the tissues due to blood flow out of theInadequate perfusion to the tissues due to blood flow out of the intravascular space causing insufficient intravascular volumeintravascular space causing insufficient intravascular volume – Anaphylactic, Septic, and Spinal ShockAnaphylactic, Septic, and Spinal Shock  Obstructive ShockObstructive Shock – Inadequate perfusion to the tissues due to obstruction of blood flowInadequate perfusion to the tissues due to obstruction of blood flow
  • 75. Hypovolemic ShockHypovolemic Shock  SIGNS & SYMPTOMSSIGNS & SYMPTOMS Low BPLow BP TachycardiaTachycardia Orthostatic HypotensionOrthostatic Hypotension RestlessnessRestlessness ConfusionConfusion Agitation (or listless)Agitation (or listless) ThirstThirst PallorPallor Cool, Clammy SkinCool, Clammy Skin ↑↑ Resp. RateResp. Rate ↓↓ UOPUOP ↓↓ COCO ↓↓ PAWPPAWP ↓↓ CVPCVP ↑↑ SVRSVR ↑↑ Lactate LevelsLactate Levels
  • 77. Cardiogenic ShockCardiogenic Shock  SIGNS & SYMPTOMSSIGNS & SYMPTOMS Low BPLow BP RestlessnessRestlessness Agitation (or listless)Agitation (or listless) ConfusionConfusion TachycardiaTachycardia PallorPallor ↓↓ UOPUOP ↓↓ COCO ↑↑ PAWP (low with RVF)PAWP (low with RVF) ↑↑CVPCVP ↑↑ SVRSVR ↑↑ Lactate LevelsLactate Levels JVDJVD Peripheral EdemaPeripheral Edema Ventricular Gallop (S3)Ventricular Gallop (S3) DyspneaDyspnea Pulmonary CracklesPulmonary Crackles
  • 78.  TREATMENTTREATMENT BedrestBedrest O2O2 ↑↑ COCO Positive InotropesPositive Inotropes ↓↓ Preload & AfterloadPreload & Afterload DiureticsDiuretics ↓↓ VasodilatorsVasodilators PositioningPositioning ↓↓ Myocardial DemandMyocardial Demand IABPIABP Cardiogenic ShockCardiogenic Shock
  • 79. Anaphylactic ShockAnaphylactic Shock  SIGNS & SYMPTOMSSIGNS & SYMPTOMS Low BPLow BP TachycardiaTachycardia RestlessnessRestlessness ConfusionConfusion Agitation (or listless)Agitation (or listless) ThirstThirst PallorPallor Warm FeelingWarm Feeling PruritusPruritus HivesHives AngioedemaAngioedema BronchoconstrictionBronchoconstriction WheezingWheezing Laryngeal EdemaLaryngeal Edema DyspneaDyspnea Cool, Clammy SkinCool, Clammy Skin ↓↓ UOPUOP ↓↓ COCO ↓↓ PAWPPAWP ↓↓ CVPCVP ↓↓ SVRSVR ↑↑ Lactate LevelsLactate Levels
  • 80.  TREATMENTTREATMENT – EpinephrineEpinephrine – IVFIVF – VasoconstrictorsVasoconstrictors – Support/Maintain AirwaySupport/Maintain Airway Anaphylactic ShockAnaphylactic Shock
  • 81. Obstructive ShockObstructive Shock  SIGNS & SYMPTOMSSIGNS & SYMPTOMS Low BPLow BP TachycardiaTachycardia RestlessnessRestlessness ConfusionConfusion Agitation (or listless)Agitation (or listless) PallorPallor Cool, Clammy SkinCool, Clammy Skin ↓↓ CO ,CO , ↓↓ UOPUOP Symptoms related to causeSymptoms related to cause
  • 82. Obstructive ShockObstructive Shock  CAUSESCAUSES Pulmonary EmbolusPulmonary Embolus TamponadeTamponade Tension PneumothoraxTension Pneumothorax Aortic AneurysmAortic Aneurysm  TREATMENTTREATMENT Treat the CauseTreat the Cause
  • 83.  Cardiogenic Shock is the only shock withCardiogenic Shock is the only shock with  PAWPPAWP  Early (Hyperdynamic) Shock is the only shock withEarly (Hyperdynamic) Shock is the only shock with  CO andCO and  SVRSVR  Neurogenic Shock is the only shock withNeurogenic Shock is the only shock with  BradycardiaBradycardia  Anaphylactic Shock has the definitive characteristic of wheezing dueAnaphylactic Shock has the definitive characteristic of wheezing due to bronchospasmto bronchospasm Parameter Hypovolemic Cardiogenic Neurogenic Anaphylactic Early Septic Late Septic CVP/RAP       PAWP      or Norm  CO       BP       SVR       HR     Normal  Shock ProfilesShock Profiles
  • 84. SIRS Sepsis Severe Septic MODS DeathSIRS Sepsis Severe Septic MODS Death InfectionInfection Sepsis ShockSepsis Shock Sepsis SyndromeSepsis Syndrome
  • 85.  Sepsis – SIRS’ response with presumed/confirmed infectionSIRS’ response with presumed/confirmed infection  Severe Sepsis – Sepsis associated with organ dysfunction, hypoperfusionSepsis associated with organ dysfunction, hypoperfusion (lactic acidosis, oliguria, altered mental status etc.), or(lactic acidosis, oliguria, altered mental status etc.), or hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)  Septic Shock – Sepsis with perfusion abnormalities and hypotensionSepsis with perfusion abnormalities and hypotension despite adequate fluid resuscitationdespite adequate fluid resuscitation Sepsis SyndromeSepsis Syndrome
  • 86.  EARLY STAGE (Hyperdynamic)EARLY STAGE (Hyperdynamic) Normal BPNormal BP TachycardiaTachycardia ConfusionConfusion Agitation (or listless)Agitation (or listless) ↑↑ Respiratory RateRespiratory Rate TemperatureTemperature Normal ColorNormal Color Normal orNormal or ↑↑ UOPUOP Normal PAWPNormal PAWP ↑↑ COCO ↓↓ SVRSVR  LATE STAGE (Hypodynamic)LATE STAGE (Hypodynamic) Low BPLow BP TachycardiaTachycardia Orthostatic HypotensionOrthostatic Hypotension RestlessnessRestlessness ConfusionConfusion Agitation (or listless)Agitation (or listless) ThirstThirst PallorPallor Cool, Clammy SkinCool, Clammy Skin ↓↓ UOPUOP ↓↓ COCO ↓↓ PAWPPAWP ↓↓ CVPCVP ↑↑ SVRSVR ↑↑ Lactate LevelsLactate Levels Septic ShockSeptic Shock
  • 88. 3.3. Improve PerfusionImprove Perfusion – Prevent organ dysfunctionPrevent organ dysfunction – Treat temp as neededTreat temp as needed 2.2. Treat The CauseTreat The Cause – Pan culture, antibioticsPan culture, antibiotics – Seek primary site of infectionSeek primary site of infection – Direct therapy to primary causeDirect therapy to primary cause 1.1. Stabilize The PatientStabilize The Patient – Fluids (lots of fluids) 150ml/hr or moreFluids (lots of fluids) 150ml/hr or more – VasoconstrictorsVasoconstrictors Treatment for SepsisTreatment for Sepsis
  • 90. Invasive PA CatheterInvasive PA Catheter CONTRAINDICATIONSCONTRAINDICATIONS  Mechanical Tricuspid or Pulmonary ValveMechanical Tricuspid or Pulmonary Valve  Right Heart Mass (thrombus and/or tumor)Right Heart Mass (thrombus and/or tumor)  Tricuspid or Pulmonary Valve EndocarditisTricuspid or Pulmonary Valve Endocarditis
  • 91. BasicBasic ConceptsConcepts  CO = HR X SVCO = HR X SV  BP = CO x SVRBP = CO x SVR  CO and SVR are inversely relatedCO and SVR are inversely related CO and SVR will change before BP changesCO and SVR will change before BP changes
  • 92. StrokeStroke VolumeVolume  Components Stroke VolumeComponents Stroke Volume – PreloadPreload:: the volume of blood in the ventriclesthe volume of blood in the ventricles at end diastole and the stretch placed on theat end diastole and the stretch placed on the muscle fibersmuscle fibers – AfterloadAfterload:: the resistance the ventricles mustthe resistance the ventricles must overcome to eject it’s volume of bloodovercome to eject it’s volume of blood – Contractility:Contractility: the force with which the heartthe force with which the heart muscle contracts (myocardial compliance)muscle contracts (myocardial compliance)
  • 93. PAC Insertion SequencePAC Insertion Sequence
  • 94. Phlebostatic AxisPhlebostatic Axis 4th ICS Mid-chest, regardless of head elevation4th ICS Mid-chest, regardless of head elevation
  • 95.  RAP (CVP)RAP (CVP)  RVPRVP  PAPPAP  PAWPPAWP  SVRSVR 0-8 mmHg0-8 mmHg 15-30/0-8 mmHg15-30/0-8 mmHg 15-30/6-12 mmHg15-30/6-12 mmHg 8 - 12 mmHg8 - 12 mmHg 700-1500700-1500 dynes/sec/cmdynes/sec/cm22 Normal Hemodynamic ValuesNormal Hemodynamic Values
  • 96. Normal Hemodynamic ValuesNormal Hemodynamic Values  Values normalized for body size (BSA)Values normalized for body size (BSA)  CI:CI: 2.5 – 4.5 L/min/m2.5 – 4.5 L/min/m22  SVRI:SVRI: 1970 – 2390 dynes/sec/cm-5/m21970 – 2390 dynes/sec/cm-5/m2  SVI or SI:SVI or SI: 35 – 60 mL/beat/m235 – 60 mL/beat/m2  EDVI:EDVI: 60 – 100 mL/m260 – 100 mL/m2
  • 97. Mixed Venous Oxygen SaturationMixed Venous Oxygen Saturation SvO2SvO2  End result of O2 delivery andEnd result of O2 delivery and consumptionconsumption  Measured in the pulmonary arteryMeasured in the pulmonary artery  An average estimate of venous saturation forAn average estimate of venous saturation for the whole body.the whole body.  Does not reflect separate tissue perfusion orDoes not reflect separate tissue perfusion or oxygenationoxygenation
  • 98. Stroke Volume Variation (SVV)Stroke Volume Variation (SVV)  Minimally Invasive Flo TracMinimally Invasive Flo Trac  Measured through Arterial LineMeasured through Arterial Line  Measures preload responsivenessMeasures preload responsiveness  SVV > 10-15 % = preload responsiveSVV > 10-15 % = preload responsive (responsive to fluids)(responsive to fluids)  SVV > 10-15% = pulsus paradoxusSVV > 10-15% = pulsus paradoxus  SVV < 10–15% = not preload responsiveSVV < 10–15% = not preload responsive
  • 99. Measuring PA PressuresMeasuring PA Pressures  Measure All Hemodynamic ValuesMeasure All Hemodynamic Values at End-Expirationat End-Expiration – ““Patient PeakPatient Peak”” – ““Vent ValleyVent Valley””
  • 101.  Measure all pressures atMeasure all pressures at end-expirationend-expiration  AtAt top curvetop curve with Spontaneous Respirationwith Spontaneous Respiration ““patient-peak”patient-peak”  Intrathoracic pressureIntrathoracic pressure decreasesdecreases duringduring spontaneous inspirationspontaneous inspiration – Negative deflection on waveformsNegative deflection on waveforms  Intrathoracic pressureIntrathoracic pressure increasesincreases duringduring spontaneous expirationspontaneous expiration – Positive deflection on waveformsPositive deflection on waveforms Measuring PA PressuresMeasuring PA Pressures
  • 102.  Measure all pressures atMeasure all pressures at end-expirationend-expiration  AtAt bottom curvebottom curve with mechanical ventilatorwith mechanical ventilator ““Vent-Valley”Vent-Valley”  Intrathoracic pressureIntrathoracic pressure increasesincreases duringduring positive pressure ventilations (inspiration)positive pressure ventilations (inspiration) – Positive deflection on waveformsPositive deflection on waveforms  Intrathoracic pressureIntrathoracic pressure decreasesdecreases duringduring positive pressure expirationpositive pressure expiration – Negative deflection on waveformsNegative deflection on waveforms Measuring PA PressuresMeasuring PA Pressures
  • 103.
  • 104.
  • 105.  a-wavea-wave – Atrial contractionAtrial contraction – Correct location for measurement of PAWPCorrect location for measurement of PAWP  Average the peak & trough of the a-waveAverage the peak & trough of the a-wave – Begins near the end of QRS or at the QTBegins near the end of QRS or at the QT segmentsegment  Delayed ECG correlation from CVP sinceDelayed ECG correlation from CVP since PA catheter is further away from left atriumPA catheter is further away from left atrium PAWP WaveformPAWP Waveform
  • 106.  c-wavec-wave – Rarely presentRarely present – Represents mitral valve closureRepresents mitral valve closure  v-wavev-wave – Represents left atrial fillingRepresents left atrial filling – Begins at about the end of the T waveBegins at about the end of the T wave PAWP WaveformPAWP Waveform
  • 108. BREAK!BREAK! CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 110. ARDSARDS  DEFINITIONSDEFINITIONS – Severe respiratory failure associated with pulmonarySevere respiratory failure associated with pulmonary infiltrates (similar to infant hyaline membrane disease)infiltrates (similar to infant hyaline membrane disease) – Pulmonary edema in the absence of fluid overload orPulmonary edema in the absence of fluid overload or depressed LV function (Non-cardiogenic pulmonary edema)depressed LV function (Non-cardiogenic pulmonary edema) – Originates from a number of insults involving damage to theOriginates from a number of insults involving damage to the alveolar-capillary membranealveolar-capillary membrane
  • 111. Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
  • 112. ARDSARDS  PATHOPHYSIOLOGYPATHOPHYSIOLOGY – Inflammatory mediators are released causing extensiveInflammatory mediators are released causing extensive structural damagestructural damage – Increased permeability of pulmonary microvasculatureIncreased permeability of pulmonary microvasculature causes leakage of proteinaceous fluid across the alveolar–causes leakage of proteinaceous fluid across the alveolar– capillary membranecapillary membrane – Also causes damage to the surfactant-producing type II cellsAlso causes damage to the surfactant-producing type II cells
  • 113. ARDSARDS  CXR CHARACTERISTICSCXR CHARACTERISTICS – Normal size heartNormal size heart – No pleural effusionNo pleural effusion – Ground GlassGround Glass appearanceappearance – Often normal early in the disease but may rapidlyOften normal early in the disease but may rapidly progress to complete whiteoutprogress to complete whiteout
  • 115. ARDSARDS  SIGNS & SYMPTOMSSIGNS & SYMPTOMS – Symptoms develop 24 to 48 hours of injurySymptoms develop 24 to 48 hours of injury  Sudden progressive disorderSudden progressive disorder  Pulmonary edemaPulmonary edema  Severe dyspneaSevere dyspnea  HypoxemiaHypoxemia REFRACTORYREFRACTORY to O2to O2  Decreased lung complianceDecreased lung compliance  Diffuse pulmonary infiltratesDiffuse pulmonary infiltrates – Symptoms may be minimal compared to CXRSymptoms may be minimal compared to CXR – Rales may be heardRales may be heard
  • 116. ARDSARDS Common RiskCommon Risk FactorsFactors Other Risk FactorsOther Risk Factors SepsisSepsis MassiveMassive TraumaTrauma ShockShock MultipleMultiple TransfusionsTransfusions PneumoniaPneumonia AspirationAspiration InfectionInfection Smoke inhalationSmoke inhalation Inhaled toxinsInhaled toxins BurnsBurns Near DrowningNear Drowning DKADKA PregnancyPregnancy EclampsiaEclampsia Amniotic Fluid EmbolusAmniotic Fluid Embolus DrugsDrugs Acute PancreatitisAcute Pancreatitis DICDIC Head InjuryHead Injury ↑ ICPICP Fat EmboliFat Emboli Blood ProductsBlood Products Heart/Lung BypassHeart/Lung Bypass Tumor LysisTumor Lysis Pulmonary ContusionPulmonary Contusion NarcoticsNarcotics  RISK FACTORSRISK FACTORS
  • 118. Chronic Lung DiseaseChronic Lung Disease  COPDCOPD – Presents with hyper-inflated lung fieldsPresents with hyper-inflated lung fields  Due to chronic air trappingDue to chronic air trapping  May be barrel chestedMay be barrel chested – May lead to cor pulmonaleMay lead to cor pulmonale (right-sided heart failure)(right-sided heart failure)  Due to chronic high pulmonary pressuresDue to chronic high pulmonary pressures – Often hypercarbic (high pCO2)Often hypercarbic (high pCO2)  Often dependent upon hypoxic driveOften dependent upon hypoxic drive
  • 119. Chronic Lung DiseaseChronic Lung Disease  COPD TREATMENTCOPD TREATMENT – Avoid overuse of oxygenAvoid overuse of oxygen (except in emergencies)(except in emergencies) – BronchodilatorsBronchodilators – SteroidsSteroids – HydrationHydration – EducationEducation  Pursed Lip BreathingPursed Lip Breathing  Leaning UprightLeaning Upright
  • 120. Near DrowningNear Drowning  Salt WaterSalt Water – Causes body fluids to shift into lungsCauses body fluids to shift into lungs  Osmosis: From low to high concentrationOsmosis: From low to high concentration  Results in hemoconcentration & hypovolemiaResults in hemoconcentration & hypovolemia – Results in acute pulmonary edemaResults in acute pulmonary edema  Fresh WaterFresh Water – Fluids shift into body tissuesFluids shift into body tissues  Results in hemodilution & hypervolemiaResults in hemodilution & hypervolemia  Can result in gross edemaCan result in gross edema – Damaged alveoli fill with proteinaceous fluidDamaged alveoli fill with proteinaceous fluid  May lead to pulmonary edemaMay lead to pulmonary edema
  • 121. PneumoniaPneumonia  Lung infection (bacterial, viral, or fungal)Lung infection (bacterial, viral, or fungal) – Most commonly caused by SMost commonly caused by Streptococcustreptococcus pneumoniaepneumoniae  Symptoms include fever, pleuretic chestSymptoms include fever, pleuretic chest pain, productive cough, and tachypneapain, productive cough, and tachypnea – Often presents bronchial breath sounds over theOften presents bronchial breath sounds over the lung arealung area  Treatment involves giving the right antibioticTreatment involves giving the right antibiotic
  • 122. PneumothoraxPneumothorax  DEFINITIONSDEFINITIONS – Simple pneumothoraxSimple pneumothorax  Results from buildup of air or pressure in the pleural spaceResults from buildup of air or pressure in the pleural space – Spontaneous pneumothoraxSpontaneous pneumothorax  May be due to blebs that ruptureMay be due to blebs that rupture  The 2 key risk factors are increased chest length andThe 2 key risk factors are increased chest length and cigarette smokingcigarette smoking – Tension pneumothoraxTension pneumothorax  Involves a buildup of air in the pleural space due toInvolves a buildup of air in the pleural space due to one-way movement of airone-way movement of air  Progressively worsensProgressively worsens  Requires immediate interventionRequires immediate intervention
  • 126. PneumothoraxPneumothorax  SIGNS & SYMPTOMSSIGNS & SYMPTOMS – Standard PneumothoraxStandard Pneumothorax  Sharp "pleuritic" chest pain, worse on breathingSharp "pleuritic" chest pain, worse on breathing  Sudden shortness of breathSudden shortness of breath  Dry, hacking cough (may occur due to irritationDry, hacking cough (may occur due to irritation of the diaphragm)of the diaphragm)  May cause mediastinal shiftMay cause mediastinal shift – Tension pneumothoraxTension pneumothorax  Signs of standard pneumothorax with signs ofSigns of standard pneumothorax with signs of cardiovascular collapsecardiovascular collapse  Immediately life threateningImmediately life threatening  May cause mediastinal shiftMay cause mediastinal shift
  • 127. PneumothoraxPneumothorax  TREATMENTTREATMENT  Spontaneous pneumothoraxSpontaneous pneumothorax – Depends on symptoms & size of pneumothoraxDepends on symptoms & size of pneumothorax – Provide respiratory supportProvide respiratory support – May need chest tube or needle decompressionMay need chest tube or needle decompression  Some resolve without interventionSome resolve without intervention  Tension pneumothoraxTension pneumothorax – RequiresRequires immediateimmediate interventionintervention – May cause cardiovascular collapseMay cause cardiovascular collapse – May need chest tube or needle decompressionMay need chest tube or needle decompression  22ndnd intercostal spaceintercostal space
  • 128.  TREATMENTTREATMENT – PleurodesisPleurodesis PneumothoraxPneumothorax  Chemical or surgical adhesion of the lungChemical or surgical adhesion of the lung to the chest wallto the chest wall  Used for multiple collapsed lungs orUsed for multiple collapsed lungs or persistent collapsepersistent collapse
  • 130.  DefinitionDefinition  Signs & SymptomsSigns & Symptoms Pulmonary EmbolismPulmonary Embolism – Arterial embolus that obstructs blood flow to the lungArterial embolus that obstructs blood flow to the lung – Symptoms include sudden dyspnea, cough, chestSymptoms include sudden dyspnea, cough, chest pain, hemoptysis and sinus tachycardiapain, hemoptysis and sinus tachycardia – Blood gas shows low pO2 & low pCO2Blood gas shows low pO2 & low pCO2 – May present positive Homan’s SignMay present positive Homan’s Sign – May present loud S2May present loud S2
  • 131.  Diagnostic TestsDiagnostic Tests – CXRCXR – VQ ScanVQ Scan – Spiral CTSpiral CT – Pulmonary arteriogram/angiogramPulmonary arteriogram/angiogram – Venous ultrasound of the lower extremitiesVenous ultrasound of the lower extremities – ABG with low pO2 & low pCO2ABG with low pO2 & low pCO2 – D-DimerD-Dimer Pulmonary EmbolismPulmonary Embolism
  • 132.  TreatmentTreatment – Requires immediate interventionRequires immediate intervention – Provide respiratory supportProvide respiratory support – Treat pain & comfortTreat pain & comfort – Usually includes intravenous heparinUsually includes intravenous heparin  Heparin reduces risk of secondaryHeparin reduces risk of secondary thrombus formation while clot is reabsorbedthrombus formation while clot is reabsorbed – May require embolectomyMay require embolectomy – May require thrombolysisMay require thrombolysis – May need umbrella filterMay need umbrella filter – May need long term anticoagulantsMay need long term anticoagulants Pulmonary EmbolismPulmonary Embolism
  • 133. Respiratory FailureRespiratory Failure  DEFINITIONSDEFINITIONS – Failure to maintain adequate gas exchangeFailure to maintain adequate gas exchange – Inadequate blood oxygenation or CO2 removalInadequate blood oxygenation or CO2 removal – PaO2 < 50 mmHg and/or PaCO2 > 50 mmHgPaO2 < 50 mmHg and/or PaCO2 > 50 mmHg and/or pH < 7.35and/or pH < 7.35 on Room Airon Room Air
  • 134. Respiratory FailureRespiratory Failure TYPE ITYPE I HypoxemiaHypoxemia withoutwithout hypercapniahypercapnia TYPE IITYPE II HypoxemiaHypoxemia withwith hypercapniahypercapnia
  • 135. Respiratory FailureRespiratory Failure  CAUSESCAUSES – V/Q MismatchingV/Q Mismatching – Intrapulmonary ShuntingIntrapulmonary Shunting – Alveolar HypoventilationAlveolar Hypoventilation
  • 136. Respiratory FailureRespiratory Failure  V/Q MISMATCHINGV/Q MISMATCHING – COPDCOPD – Interstitial Lung DiseaseInterstitial Lung Disease – Pulmonary EmbolismPulmonary Embolism
  • 137. Respiratory FailureRespiratory Failure  PULMONARY SHUNTINGPULMONARY SHUNTING – AV fistulas/malformationsAV fistulas/malformations – Alveolar collapse (atelectasis)Alveolar collapse (atelectasis) – Alveolar consolidation (pneumonia)Alveolar consolidation (pneumonia) – Excessive mucus accumulationExcessive mucus accumulation
  • 138. Respiratory FailureRespiratory Failure  SIGNS & SYMPTOMSSIGNS & SYMPTOMS – Restlessness / AgitationRestlessness / Agitation – Confusion /Confusion / ↓↓ LOCLOC – Tachycardia / DysrhythmiasTachycardia / Dysrhythmias – Tachypnea / DyspneaTachypnea / Dyspnea – Cool, clammy, pale skinCool, clammy, pale skin
  • 139. Respiratory FailureRespiratory Failure  ARTERIAL BLOOD GASESARTERIAL BLOOD GASES – pH 7.30 / pO2 45 / pCO2 80pH 7.30 / pO2 45 / pCO2 80 – pH 7.30 / pO2 55 / pCO2 65pH 7.30 / pO2 55 / pCO2 65 – pH 7.32 / pO2 50 / pCO2 50pH 7.32 / pO2 50 / pCO2 50 – pH 7.55 / pO2 65 / pCO2 22pH 7.55 / pO2 65 / pCO2 22
  • 140. Respiratory FailureRespiratory Failure  TREATMENTTREATMENT – Ensure Adequate VentilationEnsure Adequate Ventilation ↑↑ FiO2FiO2  Ineffective with shuntingIneffective with shunting  Prolonged O2 > 40% causes O2 toxicityProlonged O2 > 40% causes O2 toxicity  Must use caution with CO2 retainersMust use caution with CO2 retainers – Chronic hypercapnia causes CO2 retainersChronic hypercapnia causes CO2 retainers to use hypoxic driveto use hypoxic drive – Too much O2 can depress respirationsToo much O2 can depress respirations
  • 141. BREAK!BREAK! CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 142.  GI BleedGI Bleed  PancreatitisPancreatitis Gastrointestinal AlterationsGastrointestinal Alterations
  • 143.  CAUSESCAUSES – UGI BleedingUGI Bleeding  Includes the esophagus, stomach, duodenumIncludes the esophagus, stomach, duodenum – Peptic Ulcer Disease (PUD), or Esophageal VaricesPeptic Ulcer Disease (PUD), or Esophageal Varices – ASA, NSAID’s, Anticoagulants, AlcoholASA, NSAID’s, Anticoagulants, Alcohol – H. PyloriH. Pylori – LGI BleedingLGI Bleeding  Includes the jejunum, ileum, colon, rectumIncludes the jejunum, ileum, colon, rectum – Colorectal cancer, Polyps, Hemorrhoids, IBDColorectal cancer, Polyps, Hemorrhoids, IBD Gastrointestinal BleedingGastrointestinal Bleeding
  • 145. Gastrointestinal BleedingGastrointestinal Bleeding  HematemesisHematemesis – vomiting of blood (or coffee ground– vomiting of blood (or coffee ground material) (indicates bleeding above the duodenum )material) (indicates bleeding above the duodenum )  MelenaMelena – passage of black tarry stools > 50ml (indicates– passage of black tarry stools > 50ml (indicates degradation of blood in the bowel)degradation of blood in the bowel)  HematocheziaHematochezia – passage of red blood (rectal bleeding)– passage of red blood (rectal bleeding)  Occult BleedingOccult Bleeding – bleeding that is not apparent to the– bleeding that is not apparent to the patient and results from small amounts of bloodpatient and results from small amounts of blood  Obscure BleedingObscure Bleeding – occult or obvious but source not– occult or obvious but source not identifiedidentified
  • 146. Gastrointestinal BleedingGastrointestinal Bleeding  HematemesisHematemesis –– always UGI sourcealways UGI source  MelanaMelana –– indicates blood has been in GI tractindicates blood has been in GI tract for extended periodsfor extended periods – Mostly UGIMostly UGI – Small bowelSmall bowel – Rt colon (if bleeding relatively slow)Rt colon (if bleeding relatively slow)  HematocheziaHematochezia – Mostly colonMostly colon – Massive UGI bleeding (not enough time for degradation)Massive UGI bleeding (not enough time for degradation)
  • 147.  TREATMENTTREATMENT – Find the underlying causeFind the underlying cause – Fluid volume replacementFluid volume replacement – Endoscopy or colonoscopyEndoscopy or colonoscopy – Medical and /or surgical therapyMedical and /or surgical therapy  SomatostatinSomatostatin  IV or intra-arterial vasopressinIV or intra-arterial vasopressin  SclerotherpaySclerotherpay  Angiography with embolizationAngiography with embolization  ElectrocoagulationElectrocoagulation  Band ligationBand ligation  Balloon tamponade (Sengstaken-Blackmore tube)Balloon tamponade (Sengstaken-Blackmore tube) Gastrointestinal BleedingGastrointestinal Bleeding
  • 148. The PancreasThe Pancreas  The Pancreas secretes digestive enzymes,The Pancreas secretes digestive enzymes, bicarbonate, water, and some electrolytes intobicarbonate, water, and some electrolytes into the duodenum via the pancreatic ductthe duodenum via the pancreatic duct – Lipase, Amylase, TrypsinLipase, Amylase, Trypsin  The Pancreas also producesThe Pancreas also produces and secretes insulinand secretes insulin
  • 149. PancreatitisPancreatitis  DEFINITIONDEFINITION – An autodigestive process resultingAn autodigestive process resulting from premature activation offrom premature activation of pancreatic enzymespancreatic enzymes
  • 150. PancreatitisPancreatitis  PATHOSHYSIOLOGYPATHOSHYSIOLOGY • Inactive pancreatic enzymes are activated outsideInactive pancreatic enzymes are activated outside of the duodenumof the duodenum • The swelling pancreas causes fluids to shift intoThe swelling pancreas causes fluids to shift into the retro peritoneum and bowelthe retro peritoneum and bowel • Fluid shifts can cause severe hypovolemia andFluid shifts can cause severe hypovolemia and hypotensionhypotension • Inflammation cause commotion around pancreasInflammation cause commotion around pancreas
  • 151. PancreatitisPancreatitis  MANY CAUSESMANY CAUSES – AlcoholismAlcoholism – Biliary DiseaseBiliary Disease – GallstonesGallstones – InfectionsInfections – HyperparathyroidismHyperparathyroidism – HypertriglyceridemiaHypertriglyceridemia – HypercalcemiaHypercalcemia – Peptic Ulcer DiseasePeptic Ulcer Disease – Cystic FibrosisCystic Fibrosis – Vascular DiseaseVascular Disease – Multiple DrugsMultiple Drugs – Much Much MoreMuch Much More
  • 152. PancreatitisPancreatitis  SIGNS & SYMPTOMSSIGNS & SYMPTOMS – Abdominal PainAbdominal Pain – Nausea & VomitingNausea & Vomiting – Abdominal DistentionAbdominal Distention – JaundiceJaundice – MalnutritionMalnutrition – HematemesisHematemesis – Grey Turner’s SignGrey Turner’s Sign – Cullen’s SignCullen’s Sign – Elevated Amylase,Elevated Amylase, Lipase, LDH, AST, WBC’sLipase, LDH, AST, WBC’s BUN, and GlucoseBUN, and Glucose
  • 153. PancreatitisPancreatitis  COMPLICATIONSCOMPLICATIONS – HypocalcemiaHypocalcemia – HypotensionHypotension – Acute Tubular NecrosisAcute Tubular Necrosis – DICDIC – Obstructive JaundiceObstructive Jaundice – Erosive GastritisErosive Gastritis – Paralytic IleusParalytic Ileus – Pseudocyst or AbscessPseudocyst or Abscess – Bowel InfarctionBowel Infarction – Internal BleedingInternal Bleeding – Fat NecrosisFat Necrosis – Pleural Effusion (left)Pleural Effusion (left) – Pulmonary InfiltratesPulmonary Infiltrates – HypoxemiaHypoxemia – AtelectasisAtelectasis – ARDSARDS – Pericardial EffusionPericardial Effusion – Mediastinal AbscessMediastinal Abscess – HyperglycemiaHyperglycemia – HypertriglyceridemiaHypertriglyceridemia – EncephalopathyEncephalopathy
  • 154. PancreatitisPancreatitis  TREATMENTTREATMENT – StabilizationStabilization  Correct Fluid AndCorrect Fluid And Electrolyte StatusElectrolyte Status – Respiratory SupportRespiratory Support – Control PainControl Pain  DemerolDemerol – NG TubeNG Tube  NPONPO – TPNTPN  Restricted DietRestricted Diet – Monitor For ComplicationsMonitor For Complications – Monitor Blood SugarMonitor Blood Sugar – Drug TherapiesDrug Therapies  Somatostatin,Somatostatin, AnticholinergicsAnticholinergics – Watch For Signs OfWatch For Signs Of InfectionInfection – PrayPray
  • 155. PancreatitisPancreatitis  FULMINATING PANCREATITISFULMINATING PANCREATITIS • Overwhelming formOverwhelming form • Necrotizing formNecrotizing form • Extreme symptomsExtreme symptoms • Seen with ESRF patientsSeen with ESRF patients • May lead to ARDS & DICMay lead to ARDS & DIC
  • 156. PancreatitisPancreatitis  FULMINATING PANCREATITISFULMINATING PANCREATITIS • Signs & SymptomsSigns & Symptoms  Tachycardia & low BP (may be the only sign)Tachycardia & low BP (may be the only sign)  Pulmonary & cerebral insufficiencyPulmonary & cerebral insufficiency  Acute diabetic ketosis or oliguriaAcute diabetic ketosis or oliguria  Hemorrhagic pancreatitis may appearHemorrhagic pancreatitis may appear
  • 157. THE ENDTHE END PART 1PART 1 CCRN REVIEWCCRN REVIEW
  • 158. THANK YOUTHANK YOU CCRN REVIEW PART 1CCRN REVIEW PART 1
  • 159. ReferencesReferences  American Heart Association. (2005). Guidelines 2005 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Available at: www.americanheart.org.  Bridges EJ.(2006) Pulmonary artery pressure monitoring: when, how, and what else to use. AACN Adv Crit Care. 2006;17(3):286–303.  Chulay, M., Burns S. M. (2006). AACN Essentials of Critical Care Nursing. McGraw-Hill Companies, Inc., Chapter 23.  Finkelmeier, B., Marolda, D. (2004) Aortic Dissection, Journal of Cardiovascular Nursing: 15(4):15–24.  Hughes E. (2004). Understanding the care of patients with acute pancreatitis. Nurs Standard: (18) pgs 45-54.  Sole, M. L., Klein, D. G. & Moseley, M. (2008). Introduction to Critical Care Nursing. 5th ed. Philadelphia, Pa: Saunders.  Thelan, L. A., Urden, L. D., Lough, M. E. (2006). Critical care: Diagnosis and Treatment for repair of abdominal aortic aneurysm. St. Louis, Mo.: Mosby/Elsevier. pg 145-188.
  • 160. References ContinuedReferences Continued  Urden, L., Lough, M. E. & Stacy, K. L. (2009). Thelan's Critical Care Nursing: Diagnosis and Management (6th ed). St. Louis, Mo.: Mosby/Elsevier.  Woods, S., Sivarajan Froelicher, E. S., & Motzer, S. U. (2004). Cardiac Nursing. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins.  Wynne J, Braunwald E. (2004). The Cardiomyopathies in Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine (7th Edition). Philadelphia: W.B. Saunders, vol. 2, pps. 1659–1696, 1751–1803.  Zimmerman & Sole. (2001). Critical Care Nursing (3rd Edition). WB Saunders., pgs. 41-80, 176-180, 242-266.  Anderson, L. (July 2001). Abdominal Aortic Aneurysm, Journal of Cardiovascular Nursing:15(4):1–14, July 2001.  Irwin, R. S.; Rippe, J. M. (January 2003). Intensive Care Medicine. Lippincott Williams & Wilkins, Philadelphia: pgs. 35-548.  Wung, S., Aouizerat, B. E. (Nov/Dec 2004). Aortic Aneurysms. Journal of Cardiovascular Nursing. Lippincott Williams & Wilkins, Inc.:19(6):409-416, 34(2).

Notes de l'éditeur

  1. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  2. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  3. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 As plaque develops and the coronary arteries become increasingly narrower, collateral branches form to help supply those areas of heart muscle. MI’s with no collateral circulation tend to suffer more severe infarctions and more hemodynamic compromise. Edema and color changes (within the heart) are evident 6 hours after an MI. LV function is altered immediately in ischemic states as well as in infarctions. Wall thickness decreases 8 to 10 days later due to a natural physiological cleanup and/or necrotic tissue removal. Scar tissue and tissue remodeling occur later and may lead to cardiac failure. Transmural MI involves full thickness of the myocardium whereas subendocardial MI (non-Q wave) involves partial thickness.
  4. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Cardiac Enzymes: Troponin The troponin level rises within 4-6 hours after an AMI, peaks in 24 hours, and returns to baseline within 7-10 days. CK or CPK MB-CK is the cardiac specific isoenzyme MB-CK is normally less then 5% of the CK The CK level rises within 4-8 hours, peaks in 8-58 hours (with an average of 24 hours), and returns to baseline within 3-4 days. LDH LDH 1 is the cardiac specific isoenzyme When LDH 1 &gt; LDH 2 , an AMI is probably occurring The LDH level rises within 24-48 hours, peaks within 3-6 days, and returns to baseline within 8-14 days. False positives enzyme levels may be seen in conditions that involve muscle injury (trauma, disease, vigorous exercise or rhabdomyolysis)
  5. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  6. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Coronary Circulation: RCA Supplies the SA node, AV node, bundle of his, posterior papillary muscles, inferior wall of the left ventricle, and the posterior third of the septum The RCA supplies most of the blood supply to the inferior wall of the left ventricle for most people A person is said to be right dominant when the RCA supplies most of the blood supply to the inferior wall (of the left ventricle) IWMI usually due to RCA occlusion Watch for problems associated with the SA node (tachycardia, bradycardia, sick sinus or sinus arrest), the AV node (AV blocks), the right ventricle (RV involvement), and the posterior papillary muscles (MR or papillary muscle rupture). LAD (branches off left main artery) Supplies the anterior wall of the left ventricle, some of the lateral wall, and most of the intra-ventricular septum (including it’s conduction system) AWMI usually due to LAD occlusion Watch for problems involving large areas of the anterior left ventricle (cardiogenic shock) and problems involving the septum (blocks and VSD). Circumflex (branches off left main artery) Supplies the lateral and posterior walls of the left ventricle A small percentage of people have a short RCA and the circumflex artery then wraps around and supplies most of the inferior wall A person is said to be left dominant when the circumflex artery supplies most of the blood supply to the inferior wall (of the left ventricle) Lateral and/or posterior wall MI usually due to circumflex occlusion
  7. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  8. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Two or more leads of a group: IWMI Leads II, III and aVF view the inferior wall (of the left ventricle) Reciprocal changes are seen in leads I, and aVL AWMI Leads V 1 -V 4 view the anterior-septal wall (left ventricle) Reciprocal changes are seen in leads II, III, and AVF Lateral wall MI Leads I, aVL, V 5 and V 6 view the lateral wall (left ventricle) Reciprocal changes are seen in leads II, III, and aVF Posterior wall MI Posterior MI’s are difficult to detect on a 12 lead EKG because no leads are placed directly over the posterior Changes are reflected on the opposite walls (Instead of ST elevations, you will see ST depression. Instead of Q waves, you will see tall R waves. Instead of T wave inversions, you will see upright T waves) Reciprocal changes may be seen in leads V 1 and V 2 Right Ventricle Leads V 3 R – V 6 R view the RV
  9. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Two or more leads of a group: IWMI Leads II, III and aVF view the inferior wall (of the left ventricle) Reciprocal changes are seen in leads I, and aVL AWMI Leads V 1 -V 4 view the anterior-septal wall (left ventricle) Reciprocal changes are seen in leads II, III, and AVF Lateral wall MI Leads I, aVL, V 5 and V 6 view the lateral wall (left ventricle) Reciprocal changes are seen in leads II, III, and aVF Posterior wall MI Posterior MI’s are difficult to detect on a 12 lead EKG because no leads are placed directly over the posterior Changes are reflected on the opposite walls (Instead of ST elevations, you will see ST depression. Instead of Q waves, you will see tall R waves. Instead of T wave inversions, you will see upright T waves) Reciprocal changes may be seen in leads V 1 and V 2 Right Ventricle Leads V 6 R - V 3 R view the RV
  10. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  11. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  12. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  13. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  14. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  15. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 NTG Dilates coronary arteries Decreases preload (decreases, afterload some) MSO 4 Morphine is the analgesic of choice with AMI because it also reduces preload and decreases myocardial oxygen demand. Morphine decreases anxiety, restlessness, and autonomic nervous system activity. Aspirin Inhibits platelet aggregation Heparin Prevents further extension of existing thrombi and/or new clot formation (blocks conversion of prothrombin to thrombin and fibrinogen to fibrin) Beta Blockers Slow heart rate and lower BP Encourages electrical stability Improves mortality ACE Inhibitors Reduce afterload (vasodilatation) Reduces work of heart Decreases remolding effects GP IIb IIIa Inhibitors (anti-thrombolytics) Integrilin Reopro Thrombolytics Given up to 12 hours from the onset of an AMI Contraindicated in patients with active bleeding, BP&gt;200/120, major surgery within 2 weeks, CPR &gt;10 min, recent head trauma, suspected aortic dissection, pregnancy, CVA within 1 year, history of a hemorrhagic CVA, of major illnesses or cancers Anti-Lipidemics HDH is associated with  risk LDH is associated with  risk Look at the HDL : LDL ratio
  16. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  17. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  18. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  19. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  20. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  21. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  22. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  23. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  24. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  25. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  26. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  27. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  28. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  29. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  30. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  31. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  32. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  33. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  34. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  35. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  36. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  37. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Increased incidence of sudden death or blood clots EDV) = the volume of blood in each ventricle at the end of diastole, usually about 120–130 mL but sometimes reaching 200–250 mL in the normal heart.
  38. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Increased incidence of sudden death or blood clots
  39. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  40. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  41. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  42. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  43. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  44. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  45. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Generalized Treatment of Cardiomyopathy: Treat Symptoms Monitor For Signs of Worsening Heart Failure Daily Weights Prone To Digoxin Toxicity Due To  Renal Perfusion  Monitor Digoxin Levels Give Positive Inotropic Drugs (Except With Hypertropic Cardiomyopathy) Give Vasodilators (Except With Hypertropic Cardiomyopathy) Reduce Preload &amp; Afterload Diuretics Calcium Channel Blockers As Indicated Beta Blockers As Indicated IABP Vasodilators As Indicated Fluid Restriction Give O2 With Exacerbations &amp; As Needed Give Antidysrhythmic Agents As Needed Restrict Sodium Decrease Activity, Plan Activities &amp; Rest Consider Heart Transplant Educate Patient &amp; Family Give Emotional Support
  46. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  47. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  48. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 AFib TREATMENT O2 and monitor. Slow rate when necessary. ECG Attempt to convert with medications if relatively new rhythm and hemodynamically stable. Prepare for synchronized cardioversion if hemodynamically unstable. Chronic atrial fibrillation usually treated with coumadin, ASA, etc.
  49. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 AFL TREATMENT O2 and monitor. ECG Attempt to convert with medications if relatively new rhythm and hemodynamically stable (beta-blockers, calcium channel blockers, digoxin). Prepare for synchronized cardioversion if hemodynamically unstable.
  50. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 WAP TREATMENT O2 and monitor ECG
  51. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Atrial or Supraventricular tachycardia (SVT) is a fast heart rate that starts in the upper chambers of the heart. Some forms are called paroxysmal atrial tachycardia (PAT) or paroxysmal supraventricular tachycardia (PSVT). SVT TREATMENT O2 and monitor. ECG May attempt vagal maneuvers. May require beta-blockers, calcium channel blockers, etc. Prepare for synchronized cardioversion if hemodynamically unstable.
  52. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 VT TREATMENT Immediate defibrillation or cardioversion. CPR and ACLS
  53. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Torsades TREATMENT MgSO4 Immediate defibrillation. CPR and ACLS.
  54. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  55. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Pulmonary (LVF) and/or systemic (RVF) congestion is present. The weakened LV doesn’t empty properly and backs up toward the pulmonary vasculature. The increased pressures allow fluid to leak back into the pulmonary interstitial spaces and into the alveolus. Back pressure form the RV to the systemic venous system leads to increased venous pressures with engorgement of the liver and spleen and third-spacing of fluid into interstitial spaces, causing peripheral edema and ascites.
  56. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Cardiogenic Pulmonary Edema = Elevated PAP, Elevated PAWP Non-cardiogenic Pulmonary Edema = Elevated PAP, Normal PAWP
  57. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 When blood volume is low, juxtaglomerular cells in the kidneys secrete renin directly into circulation. Plasma renin then carries out the conversion of angiotensinogen released by the liver to angiotensin I. Angiotensin I is subsequently converted to angiotensin II by the enzyme angiotensin converting enzyme found in the lungs.
  58. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Class I: Patient with cardiac disease without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, dyspnea or angina.   Class II: Patient with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest but ordinary physical activity results in fatigue, palpitations, dyspnea or angina. Class III: Patient with cardiac disease resulting in marked limitations of physical activity. They are comfortable at rest but, less than ordinary activity causes fatigue, palpitations, dyspnea or angina. Class IV: Patient with cardiac disease resulting in inability to do any physical activity without discomfort. Symptoms of cardiac insufficiency or angina are increased when any activity is attempted.  
  59. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  60. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 OPTIMIZE CARDIAC OUTPUT Improve Oxygenation O 2 Intubation PEEP Diuretics Decrease Myocardial Oxygen Consumption Bedrest (HOB elevated) Physical comfort (temperature control) Emotional control (keep informed, sedative prn) Gradually increase activity as tolerated, rest between activities Decrease Preload Diuretics (usually loop diuretics such as furosemide) High fowler’s position (legs dependent) Venous vasodilator (NTG, MSO 4 ) Sodium and fluid restriction Increase Contractility Cardiac glycosides (digoxin) Positive Inotropics (dopamine, dobutamine) Decrease Afterload Ace Inhibitors (captopril, enalapril) Nitroprusside (if hypertensive) Calcium channel blockers Dobutamine, Primacor Pulmonary vasodilators (aminophylline) IABP Prevent Valsalva Maneuvers Stool softeners Exhaling when turning Manage Dysrhythmias Atrial: Digoxin may be used to decrease ventricular rate by increasing refractoriness of the AV node. Ventricular: Lidocaine or amiodarone if necessary (procainamide and bretlium may significantly decrease contractility) Beta Blockers Used for mild CHF Protects heart form excessive catecholamines Cor Pulmonale (RVF) O 2 Therapy Pulmonary Vasodilators RVF Due to Pulmonary Embolus O 2 Therapy Anticoagulants Thrombolytics (if significant RVF or hypoxia)
  61. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  62. COMMON CRITICAL CONDITIONS Part One July 2004November 2002          
  63. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  64. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  65. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Hypovolemic Shock Inadequate perfusion to the tissues due to insufficient intravascular volume.   Cardiogenic Shock Inadequate perfusion to the tissues due to heart failure.   Distributive Shock (Anaphylactic, Septic, and Spinal Shock) Inadequate perfusion to the tissues due to maldistribution of blood flow out of the intravascular space causing insufficient intravascular volume.   Obstructive Shock Inadequate perfusion to the tissues due to obstruction of blood flow. Causes: Pulmonary Embolus Tamponade Tension Pneumothorax Aortic Aneurysm
  66. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  67. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  68. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Orthostatic Hypotension
  69. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  70. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Self destructive form of shock High mortality rate (75-100%) Occurs in 10% of AMI’s Usually means loss of at least 40% LV function Ventricular gallop = S3
  71. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Optimize Cardiac Output
  72. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Histamines cause massive vasodilatation
  73. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  74. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Causes of Obstructive Shock: Pulmonary Embolus Tamponade Tension Pneumothorax Aortic Aneurysm
  75. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Cardiac Tamponade &amp; Beck’s Triad: 1. Low BP 2. Distended Neck Veins 3. Muffled Heart Sounds May have Narrowed Pulse
  76. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  77. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 MODS = Multiple Organ Dysfunction Syndrome
  78. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Definitions – ACCP/SCCM Consensus Conference Definition Bone et al.1992. Chest 101:1644-1655. Sepsis: a systemic inflammatory response to infection Severe Sepsis: systemic inflammation, coagulation and impaired fibinolysis. Septic Shock: severe sepsis defined as sepsis-induced hypotension (systolic blood pressure &lt; 90mmHg or a reduction of=40mmHg from baseline in the absence of other causes for hypotension) despite adequate fluid resuscitation along with the presence of perfusion abnormalities. Patients receiving inotropic or vasopressor agents may no longer be hypotensive by the time that they manifest hypoperfusion abnormalities or organ dysfunction, yet they would be considered having septic shock.
  79. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Toxins and bradykinins cause massive vasodilatation, a positive inotropic effect and stimulate the respiratory rate. May cause release of myocardial depressant factor in late phase. May stimulate the clotting cascade. Often leads to ARDS or/and DIC.
  80. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Optimize intravascular volume Consider Xygris (Activated Protein C)
  81. Definition: Measuring and monitoring the factors that influence the force and flow of blood. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  82. The Fick Principle : Calculates consumption of O2 over time NIC0 : Partial CO2 rebreathing (NICO) Thermodilution : PA Catheter TEBCO : Electrical impedance of the thorax (TEB) NICCO : ECHO : Uses doppler ultrasound MUGA Scan : Nuclear heart scan SVV : CCO, SVV / SV, SVR COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  83. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  84. 1) Normal Values: CVP = 1-7 mmHg PAWP = 6-12 mmHg CO = 4.0-8.0 L/Min. CI = 2.5-4.0 L/Min. SVR = 700=1500 dynes/sec/cm 5 PVR = 100-250 dynes/sec/cm 5 RVSW = 10-15 gm 2 /beat LVSW = 60-80 gm 2 /beat COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  85. 1) Normal Values: CVP = 1-7 mmHg PAWP = 6-12 mmHg CO = 4.0-8.0 L/Min. CI = 2.5-4.0 L/Min. SVR = 700=1500 dynes/sec/cm 5 PVR = 100-250 dynes/sec/cm 5 RVSW = 10-15 gm 2 /beat LVSW = 60-80 gm 2 /beat COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  86. Normal SvO2 = 75% COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  87. SVV: Arterial pulse pressure falls during inspiration and rises during expiration due to changes in intra-thoracic pressure secondary to negative pressure ventilation. Variations over 10mmHg have been referred to as pulsus paradoxus. Pulsus Paradoxus is the origin of SVV value. Occurs with spontaneously breathing patients. Reverse Pulsus Paradoxus occurs during positive pressure ventilation. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  88. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  89. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Looks like a CVP waveform, but the timing is different
  90. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Looks like a CVP waveform – just occurs later
  91. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  92. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  93. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  94. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  95. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  96. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  97. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  98. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  99. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  100. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  101. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  102. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  103. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  104. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  105. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  106. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  107. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  108. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  109. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  110. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  111. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  112. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  113. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 May do carotid ultrasound.
  114. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  115. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  116. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Type I often preceded Type II.
  117. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  118. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 In COPD, bronchospasm, mucus plugs, inflammation and airway obstruction in general worsen ventilation disrupting the balance between ventilation and perfusion.
  119. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  120. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  121. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  122. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  123. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  124. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  125. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  126. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  127. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Somatostatin is classified as an inhibitory hormone, whose main actions are to: Inhibit the release of growth hormone (GH) Inhibit the release of thyroid-stimulating hormone (TSH) Suppress the release of gastrointestinal hormones Gastrin Cholecystokinin (CCK) Secretin Motilin Vasoactive intestinal peptide (VIP) Gastric inhibitory polypeptide (GIP) Enteroglucagon (GIP) Lowers the rate of gastric emptying, and reduces smooth muscle contractions and blood flow within the intestine. Suppress the release of pancreatic hormones Inhibit the release of insulin Inhibit the release of glucagon Suppress the exocrine secretory action of pancreas. Somatostatin opposes the effects of Growth Hormone-Releasing Hormone (GHRH)
  128. COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Sphincter or Oddi
  129. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  130. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  131. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  132. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  133. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  134. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  135. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  136. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  137. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
  138. COMMON CRITICAL CONDITIONS Part One July 2004November 2002